ReportWire

Tag: Health Care

  • Doctors warn of

    Doctors warn of

    [ad_1]

    Doctors warn of “tripledemic” amid health care worker shortage – CBS News


    Watch CBS News



    Cases of the flu, RSV and COVID-19 are expected to spike this winter. Dr. Celine Gounder joins CBS News to talk about what you can do to protect your family, and how a shortage of health care workers could make things even more difficult.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • RSV in children: Symptoms, treatment and what parents should know | CNN

    RSV in children: Symptoms, treatment and what parents should know | CNN

    [ad_1]



    CNN
     — 

    In September, an 8-month-old baby came into Dr. Juanita Mora’s office in Chicago with an infection the doctor hadn’t expected to see for another two months: RSV.

    Like her peers across the country, the allergist and immunologist has been treating little ones with this cold-like virus well before the season usually starts.

    “We’re seeing RSV infections going rampant all throughout the country,” Mora said.

    Almost all children catch RSV at some point before they turn 2, the US Centers for Disease Control and Prevention says. Most adults who catch it have a mild illness; for those who are elderly or who have chronic heart or lung disease or a weakened immune system, it can be dangerous. But RSV can be especially tricky for infants and kids.

    Mora, a volunteer medical spokesperson for the American Lung Association, says it’s important for parents, caregivers and daycare workers to know what to watch for with RSV, which stands for respiratory syncytial virus. That way, they know whether a sick child can be treated at home or needs to go to a hospital.

    “The emergency department is getting completely flooded with all these sick kids, so we want parents to know they can go to their pediatrician and get tested for RSV, influenza and even Covid-19,” Mora said.

    Here’s what else parents need to know amid the surge of respiratory illnesses.

    For many, RSV causes a mild illness that can be managed at home.

    On average, an infection lasts five days to a couple of weeks, and it will often go away on its own, the CDC says. Sometimes, the cough can linger for up to four weeks, pediatricians say.

    Symptoms may look like a common cold: a runny nose, a decreased appetite, coughing, sneezing, fever and wheezing. Young infants may seem only irritable or lethargic and have trouble breathing.

    Not every child will have every potential RSV symptom.

    “Fevers are really hit or miss with RSV infections, especially in young infants,” said Dr. Priya Soni, assistant professor of pediatric infectious diseases at Cedars Sinai Medical Center.

    Parents should watch for any changes in behavior, she said, including taking longer to eat or not being interested in food at all. The child can also develop a severe cough and some wheezing.

    It’s also important to watch for signs that your child is struggling to breathe or breathing with their ribs or belly – “symptoms which may kind of overlap with many of the other viruses that we’re seeing a resurgence of,” Soni added.

    Since it’s not easy for parents to tell the difference between respiratory illnesses like, say, RSV and flu, it’s good to take a sick child to a pediatrician, who can run tests to pinpoint the cause.

    “You may need to take your baby to be evaluated sooner rather than later,” Soni said.

    When it comes to RSV, parents should be especially cautious if their children are preemies, newborns, children with weakened immune systems or neuromuscular disorders, and those under age 2 with chronic lung and heart conditions, the CDC says.

    “Parents should be really astute to any changes, like in their activity and their appetite, and then pay particular attention to any signs of respiratory distress,” Soni said.

    Testing is important because treatment for things like flu and Covid-19 may differ.

    There’s no antiviral or specific treatment for RSV like there is for the flu, nor is there a vaccine. But if your child is sick, there are things you can do to help.

    Fever and pain can be managed with non-aspirin pain relievers like acetaminophen or ibuprofen. Also make sure your child drinks enough fluids.

    “RSV can make kids very dehydrated, especially when they’re not eating or drinking, especially when we’re talking infants,” Mora said. “Once they stop eating or their urine output has decreased, they’re not having as many wet diapers, this is a sign they may have to go to the pediatrician or emergency department.”

    Talk to your pediatrician before giving your child any over-the-counter cold medicines, which can sometimes contain ingredients that aren’t good for kids.

    Your pediatrician will check the child’s respiratory rate – how fast they’re breathing – and their oxygen levels. If your child is very sick or at high risk of severe illness, the doctor may want them to go to a hospital.

    “RSV can be super dangerous for some young infants and younger kids, particularly those that are less than 2 years of age,” Soni said.

    Mora said labored breathing is a sign that a child is having trouble with this virus. RSV can turn into more serious illnesses such as bronchiolitis or pneumonia, and that can lead to respiratory failure.

    If you see that a child’s chest is moving up and down when they breathe, if their cough won’t let them sleep or if it’s getting worse, “that might be a sign that they need to seek help from their pediatrician or take them to the emergency department, because then they might need a supplemental oxygen, or they may need a nebulization treatment.”

    CNN medical analyst Dr. Leana Wen says this respiratory difficulty – including a bobbing head, a flaring nose or grunting – is one of two major trouble signs with any respiratory infection. The other is dehydration. “That particularly applies to babies with stuffy noses. They may not be feeding.”

    Much of the care provided by hospital staff will be to help with breathing.

    “We provide supportive measures for RSV and these kids with oxygen, IV fluids and respiratory therapies, including suctioning,” Soni said.

    A thin tube may need to be inserted into their lungs to remove mucus. A child can get extra oxygen through a mask or through a tube that attaches to their nose. Some children may need to use an oxygen tent. Those who are struggling a lot may need a ventilator.

    Some babies might also need to be fed by tube.

    The best ways to prevent RSV infections, doctors say, is to teach kids to cough and sneeze into a tissue or into their elbows rather than their hands. Also try to keep frequently touched surfaces clean.

    If a caregiver or older sibling is sick, Mora says, they should wear a mask around other people and wash their hands frequently.

    And most of all, if anyone is sick – child or adult – they should stay home so they don’t spread the illness.

    There is a monoclonal antibody treatment for children who are at highest risk for severe disease. It’s not available for everyone, but it can protect those who are most vulnerable. It comes in the form of a shot that a child can get every month during the typical RSV season. Talk to your doctor about whether your child qualifies.

    [ad_2]

    Source link

  • CDC shoots down false claims it will mandate COVID-19 vaccines for schoolchildren, saying states make that decision

    CDC shoots down false claims it will mandate COVID-19 vaccines for schoolchildren, saying states make that decision

    [ad_1]

    The Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that the authority for that decision lies with states and other local entities.

    The false claim spread after it was shared by Fox News host Tucker Carlson in a tweet this week, as the Associated Press reported. 

    Carlson tweeted that the agency would make the vaccine mandatory in order for children to attend school, a claim the CDC quickly shot down. While an advisory committee to the CDC voted to recommend that the vaccine be added to immunization schedules, the CDC “only makes recommendations for use of vaccines, while school-entry vaccination requirements are determined by state or local jurisdictions,” CDC spokeswoman Kate Grusich told the AP.

    Grusich explained that the action was meant to streamline clinical guidance for healthcare providers by adding COVID-19 vaccines to a single list of all currently licensed, authorized and routinely recommended vaccines.

    “It’s important to note that there are no changes in COVID-19 vaccine policy,” she said.

    The news comes as U.S. known cases of COVID are continuing to ease and now stand at their lowest level since mid-April, although the true tally is likely higher given how many people overall are testing at home, where data are not being collected.

    The daily average for new cases stood at 38,077 on Thursday, according to a New York Times tracker, down 8% from two weeks ago. Cases are currently rising in 14 states, as well as Washington, D.C., and Puerto Rico.

    The daily average for hospitalizations was down 2% to 26,669, although hospitalizations are rising in almost all northeastern states as cold weather arrives. The daily average for deaths was down 7% to 360.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Pfizer
    PFE,
    +4.42%

    is planning to sell the COVID vaccine it developed with German partner BioNTech
    BNTX,
    +9.88%

    for $110 -$130 a dose once the U.S. market for COVID-19 shots becomes commercial, likely in the first quarter of next year, MarketWatch’s Jaimy Lee reported. Pfizer and BioNTech are currently paid $30.50 per vaccine dose by the U.S. government, which contracted with the companies, as well as with other vaccine makers like Moderna
    MRNA,
    +9.07%

    and Novavax
    NVAX,
    +11.35%
    ,
    and then made the COVID-19 shots available at no cost to people in the U.S. during the public-health emergency. The emergency declaration in the U.S. isn’t expected to be renewed next year, which will lead to the formation of an official commercial market for COVID-19 vaccines, tests and treatments. 

    • Johnson & Johnson
    JNJ,
    +1.91%

    said the volume of surgical procedures is returning to prepandemic levels in many parts of the world, a trend that cheered Wall Street and could bode well for other medical-technology heavyweights like Stryker Corp.
    SYK,
    +0.57%

    and Zimmer Biomet Holdings
    ZBH,
    +0.18%
    .
    J&J, which reported earnings this week, said its medical-technology business had a “strong September,” with U.S. sales of hip and knee implants and other surgical devices rising 7.7% to $3.3 billion in the third quarter of the year. “We are seeing procedures recovering,” Ashley McEvoy, worldwide chair of J&J’s MedTech business, told investors during this week’s earnings call. “In the U.S., we started to see surgical procedures tick up, predominantly at the latter part of the quarter.”

    The new bivalent vaccine might be the first step in developing annual COVID shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to COVID could be challenging. Illustration: Ryan Trefes

    • “As China’s ruling Communist Party holds a congress this week, many Beijing residents are focused on an issue not on the formal agenda: Will the end of the meeting bring an easing of China’s at times draconian ‘zero-COVID’ policies that are disrupting lives and the economy?” the AP reported. It appears to be wishful thinking. As the world moves to a postpandemic lifestyle, many across China have resigned themselves to lining up several times a week for COVID tests, restrictions on travel to other regions and the ever-present possibility of a community lockdown.

    • Fantasy Fest, a 10-day annual party, is kicking off in Key West, Fla., on Friday, with a full slate of events for the first time since the pandemic started, the AP reported. “Due to the COVID pandemic, this will be the first full Fantasy Fest since 2019,” the festival’s board chair, Steve Robbins, said. “So I know our guests and staff are excited about getting back to the real Fantasy Fest.” Dozens of themed events are set for the festival, including a nighttime parade Oct. 29 featuring floats and elaborately costumed marching groups. Participants are encouraged to draw costume ideas from the festival’s theme, “Cult Classics & Cartoon Chaos,” and to portray characters inspired by favorite cartoons and television or film productions with a cult following.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 626.9 million on Friday, while the death toll rose above 6.57 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97.2 million cases and 1,067,190 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.5 million people living in the U.S., equal to 68.2% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 111.4 million have had a booster, equal to 49.1% of the vaccinated population, and 26.8 million of those who are eligible for a second booster have had one, equal to 40.6% of those who received a first booster.

    The CDC reports that some 19.4 million people have had a dose of the updated bivalent booster that targets omicron and its subvariants along with the original virus.

    [ad_2]

    Source link

  • ERs Seeing Huge Rise in Cases of Sexual Assault

    ERs Seeing Huge Rise in Cases of Sexual Assault

    [ad_1]

    By Steven Reinberg 

    HealthDay Reporter

    FRIDAY, Oct. 21, 2022 (HealthDay News) — Victims of sexual assault are seeking treatment in U.S. emergency rooms in growing numbers, with University of Michigan (UM) researchers detecting a 15-fold increase between 2006 and 2019.

    Rapes and other forms of sexual assault occur every 68 seconds in the United States, and their number rose from 93,000 in 2006 to nearly 140,000 in 2019, according to data from the U.S. Federal Bureau of Investigation.

    The increase in people seeking emergency medical care after sexual violence, however, is greater than the growth of those turning to the police for help, the study authors said.

    And while there are more sexual assaults occurring, greater awareness and hospital coding changes are also contributing to the spike, the researchers noted.

    “Overall destigmatization — whether that’s due to the Me-Too movement or other social-political movements — have made people feel safer coming and seeking care,” said lead researcher Emily Vogt, a UM medical student.

    It’s not clear if people who go to the ER after a sexual assault are not going to the police, Vogt added. Perhaps “they feel like that’s the only place they can go,” she said.

    For the study, Vogt and her colleagues used data from millions of emergency department visits. They found that in 2006, more than 3,600 men and women aged 18 to 65 sought emergency care following a sexual assault. In 2019, that number jumped to nearly 55,300. (For support, contact RAINN, the Rape, Abuse and Incest National Network hotline).

    Vogt’s team found that those seeking ER treatment were disproportionally younger women and poorer.

    However, despite the rise in ER care, hospital admissions after a sexual assault decreased by 8% — from just under 13% to 4%. Most patients (95%) were sent home, the findings showed.

    Admissions may have dropped because of lack of insurance, fewer empty beds, or victims not wanting to be hospitalized due to privacy concerns, Vogt said.

    Patients who were admitted tended to be poorer and have Medicaid. Victims aged 46 to 65 were also more likely to be hospitalized than younger people, possibly because the assault exacerbated other medical conditions, Vogt said.

    Overall, emergency department visits increased by 23% during the same period, with sexual assault accounting for less than 1% of visits. Yet hospital charges for sexual assault visits topped $233 million in 2019, up from $6 million in 2006, the researchers reported.

    ERs can do better in helping patients after a sexual assault, Vogt said. “The emergency department, even though it’s a better place to go than nowhere, is probably not the best place. We need better kinds of outpatient care,” she suggested.

    Vogt anticipates sexual assault numbers will continue to swell. “We didn’t even get to look at the years of the COVID-19 pandemic, which we already know from other studies has certainly increased rates of sexual assault,” she explained.

    “A lot of these patients are getting sent home, and it’s unclear whether they are getting the attention they deserve,” Vogt said. “We know these patients are at higher risk for [post-traumatic stress disorder], substance abuse, and psychiatric problems as a result of the trauma they’ve experienced.”

    The report was published online Oct. 20 in JAMA Network Open.

    Dr. Elizabeth Miller is a professor of pediatrics at the University of Pittsburgh School of Medicine. She said sexual violence remains a significant public health concern.

    “Sexual violence reporting and care-seeking is not evenly distributed across populations, and inequities persist,” Miller said. “The health consequences of sexual violence remain underrecognized by our health system, especially among survivors who are marginalized because of sexism, racism, heterosexism and ableism,” added Miller, co-author of an accompanying journal editorial.

    Miller agreed there is both increased awareness of sexual violence and growing incidence.

    “As a result of lots of community campaigns to make the experiences of sexual assault more visible, more people appear to be seeking care. But it does appear globally, we saw an increase in interpersonal violence, including childhood sexual abuse, sexual assault and intimate partner violence during the pandemic,” she said.

    And, she pointed out that people who are already marginalized because of gender identity, sexual minorities, females and people with disabilities experience higher incidences of sexual violence.

    Miller added that survivors of sexual assault should expect to be treated with respect by law enforcement and by emergency room staff. “They should know that they can also ask for a trained sexual assault nurse examiner, and they can also ask for a victim services advocate to be present during a forensic exam,” she said.

    However, more is needed to improve survivor-centered care in ERs. “We need to understand how best to provide meaningful support for survivors and to not contribute to retraumatizing individuals who have experienced an assault,” Miller said.

    [ad_2]

    Source link

  • Open enrollment: Employees have big changes to consider — here’s what to know.

    Open enrollment: Employees have big changes to consider — here’s what to know.

    [ad_1]

    Employers typically offer a period of open enrollment in the fall, when their workers are allowed to pick new health plans, enroll in a Flexible Spending Account or make other changes to their benefits. This year, there are some changes ahead that could help  employees, while also potentially opening up some financial pitfalls. 

    Among the biggest changes for 2023 are with two tax-advantaged health savings accounts — Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA). These accounts can save workers a nice chunk of change by allowing them to sock away pre-tax money to pay for medical expenses. Basically, you save what you would have paid in taxes on money you put in the accounts. 

    In 2023, employees can put away as much as $3,050 in an FSA, an increase of about 7% from the current tax year’s cap of $2,850. Meanwhile, single workers who want to fund an HSA can save up to $3,850 next year, a 5.5% increase from 2022, while families can save up to $7,750, up 6.2%.

    Those increases are helpful at a time when inflation is at it highest in four decades, with consumer prices having jumped more than 8% from a year ago. But there are several “gotchas” that workers need to be aware of, especially when it comes to Flexible Spending Accounts, with the foremost being that FSAs are “use-it-or-lose-it” programs. In other words, if you don’t use all the money you set aside, you’ll lose it — your employer keeps any unused funds.

    “Open enrollment typically opens in late October and early November,” said Lisa Myers, director of client services, benefits accounts, at Willis Towers Watson. “Planning carefully is important, and knowing the deadlines.”

    Indeed, U.S. workers end up forfeiting a total of about $3 billion a year in unused FSA funds, according to an analysis from Money. 

    Here’s what to consider during open enrollment. 

    What’s the difference between an FSA and HSA? 

    Both accounts are aimed at helping workers pay for medical expenses with pre-tax money. The biggest difference is that FSAs are controlled by your employer, while HSAs are owned by the individual. 

    That means that if you leave your job, your FSA won’t move with you. But once you open and fund an HSA, that account does stay with you, like your 401(k), which continues to be yours even after you leave a job and start at a new employer. 

    Another big difference: Health Savings Accounts are designed for people with high-deductible health care plans. This means that not every employee will have access to an HSA. 

    HSAs generally have more flexibility than FSAs. For instance, unused funds roll over each year, unlike with a FSA, where funds are forfeited if not used by your employer’s claim deadline. And you can change your contributions to your HSA at any time; with a FSA, contributions are set during open enrollment. 

    Can I enroll in both an FSA and HSA? 

    Generally, no, noted Myers of Willis Towers Watson. However, people with HSAs can opt for a slimmed-down version of a Flexible Spending Account, known as a “limited purpose FSA.” These accounts can only be used for vision and dental expenses, which shrinks their usefulness.

    That means employees who qualify for both programs will generally need to decide whether it makes more sense to fund either an FSA or an HSA for 2023.

    How much should I set aside for 2023?

    Some employers offer tools to help workers estimate their potential annual health costs, but you can also look at your out-of-pocket medical expenses for the past year to help gauge your likely expenditures for the upcoming year, Myers said.

    People with HSAs also may want to set aside the amount that they’ll pay due to their health plan deductible, since that’s out-of-pocket spending that they could get reimbursed through that tax-advantaged account. 

    There’s more at stake for people who are opting for FSAs, since overestimating your medical expenses could leave money sitting in your account that eventually returns to your employer. 

    What deadlines should I be aware of? 

    You’ll need to stay on top of the deadline for claiming your FSA funds. 

    Employers can give employees a grace period of up to two and a half months after the end of a calendar year to claim the money. But you’ll have to check if your company offers extra time and mark on your calendar when you’ll need to claim the money by.

    Some employees may be surprised by deadlines this year because a pandemic stimulus bill and the IRS relaxed the rules for claiming FSA funds, providing more time for people to file claims in 2020 and 2021. But those provisions have expired, which means people with FSAs in 2022 must claim their money by year-end or by an employer’s grace period in early 2023.

    “That was temporary relief due to the pandemic, so employees may have larger than usual balances in their health and dependent-care FSAs, and that they may forfeit going into 2023,” Myers said. “It’s important to check your balances, check the plan rules, so they can plan their spending for the remainder of 2022.”

    What can I spend my FSA money on?

    Employees are sometimes surprised at what their FSA plans will cover, including Band-Aids, reading glasses, first-aid kits and over-the-counter medicine, Myers said. 

    She recommends that people check the FSAStore.com, which carries all FSA-eligible items, especially if you are getting close to your deadline for claiming your funds and need to use the money. 

    Myers also advises that you check your 2022 FSA balance and claim deadlines now, rather than waiting until the end of the year. Generally, a health service or good must be purchased in 2022 to qualify for a 2022 FSA claim, so waiting until the last minute to try to spend the funds could increase your risk of running into a barrier — such as if your eye doctor is booked up, which could hinder renewing your prescription to get new glasses.

    [ad_2]

    Source link

  • Two new COVID variants are spreading fast in New York region and could account for about 37% of new cases

    Two new COVID variants are spreading fast in New York region and could account for about 37% of new cases

    [ad_1]

    The two newly identified omicron subvariants, dubbed BQ.1 and BQ.1.1, are spreading fast in the New York region and could account for about 37% of new cases, according to Centers for Disease Control and Prevention data crunched by NBC News.

    The two variants accounted for 11.5% and 8% of new cases, respectively, that were recorded in the area in the week ending Oct. 15, up from 4.1% and 1.9% two weeks earlier. The New York area includes New Jersey, Puerto Rico and the Virgin Islands.

    Combined, they accounted for 11.4% of overall U.S. cases in the same week. Before last Friday’s data release, they were included in BA.5 variant data, as the numbers were too small to break out. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places. The CDC is updating the numbers every Friday.

    “When you get variants like that, you look at what their rate of increase is as a relative proportion of the variants, and this has a pretty troublesome doubling time,” Anthony Fauci, President Joe Biden’s chief medical adviser, said in an interview with CBS News earlier this week.

    The news comes as experts fear another wave of cases during the winter months as colder weather forces people indoors and families gather for holidays.

    U.S. known cases of COVID are continuing to ease and now stand at their lowest level since mid-April, although the true tally is likely higher given how many people overall are testing at home, where the data are not being collected.

    The daily average for new cases stood at 37,888 on Tuesday, according to a New York Times tracker, down 15% from two weeks ago. Cases are currently rising in 10 states: Nevada, New Hampshire, New Mexico, Oklahoma, Maryland, Wisconsin, Illinois, Vermont, Kansas and Florida. Cases are also rising in Washington, D.C.

    The daily average for hospitalizations was down 6% to 25,845, although hospitalizations are up in many northeastern states, including Rhode Island, New Hampshire, New Jersey, New York, Massachusetts, Delaware, Pennsylvania and Maine.

    The daily average for deaths is down 3% to 382.

    In other news, the World Health Organization said its emergency committee came away from a meeting last week with the determination that the pandemic remains a global health emergency, despite recent progress.

    WHO Director General Tedros Adhanom Ghebreyesus said he agreed with that decison.

    “The committee emphasized the need to strengthen surveillance and expand access to tests, treatments and vaccines for those most at-risk, and for all countries to update their national preparedness and response plans,” Tedros told reporters at a briefing.

    “While the global situation has obviously improved since the pandemic began, the virus continues to change, and there remain many risks and uncertainties,” he said. “This pandemic has surprised us before and very well could again.”

    The new bivalent vaccine might be the first step in developing annual COVID-19 shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to COVID could be challenging. Illustration: Ryan Trefes

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Reports that a 16-year-old girl has died at a COVID quarantine center in China are causing anger after her family said their pleas for medical help were ignored, the Guardian reported. Videos of the girl have spread across Chinese social media in the last 24 hours. The distressing footage, which the Guardian said it has not been able to independently verify, shows the teenager ill, struggling to breathe and convulsing in a bunk bed at what is purported to be a quarantine center in Ruzhou, Henan province. The reports come as Communist Party leaders hold their party congress in Beijing amid anger about the country’s strict zero-COVID policy.

    • Hong Kong, which is experiencing a massive brain drain thanks to the pandemic and to political upheaval, unveiled a new visa scheme on Wednesday that aims to attract global talent, the Associated Press reported. The region’s chief executive, John Lee, said the Top Talent Pass Scheme will allow people who earn an annual salary of 2.5 million Hong Kong dollars ($318,472) or more, as well as graduates of the world’s top universities, to work or pursue opportunities in the city for two years.

    In a rare display of defiance, two banners unfurled from a highway overpass in Beijing condemned Chinese President Xi Jinping and his strict COVID policies. The protest took place days before the Communist Party congress in that city.

    • The COVID pandemic catalyzed a major shift in the way Americans live and work, and a new analysis from the Federal Reserve Bank of New York shows that workers in the U.S. are taking advantage of the widespread shift toward remote work to spend more time sleeping and engaging in leisure activities, MarketWatch’s Chris Matthews reported. “One of the most enduring shifts [resulting from the pandemic] has occurred in the workplace, with millions of employees making the switch to work from home,” wrote David Dam, a former New York Fed research analyst, in a Tuesday blog post.

    • The North Dakota Department of Health stored thousands of COVID-19 vaccine doses at incorrect temperatures or without temperature data over the past two years, according to a state audit Tuesday that said some of those vaccines were administered to patients, the AP reported. The health department disputed the findings. Tim Wiedrich, who heads the agency’s virus response, said “no non-viable vaccine” was given to patients. In responses that accompanied the audit, the department said clerical errors or other errors of documentation erroneously suggested that expired or bad doses were given.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 625.7 million on Wednesday, while the death toll rose above 6.57 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97 million cases and 1,065,841 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.2 million people living in the U.S., equal to 68.1% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 110.8 million have had a booster, equal to 49% of the vaccinated population, and 25.6 million of those who are eligible for a second booster have had one, equal to 39% of those who received a first booster.

    Some 14.8 million people have had a dose of the updated bivalent booster that targets omicron and its subvariants along with the original virus.

    [ad_2]

    Source link

  • Alliant Health Solutions Receives Substance Abuse and Mental Health Services Administration Center of Excellence for Behavioral Health in Nursing Facilities Grant

    Alliant Health Solutions Receives Substance Abuse and Mental Health Services Administration Center of Excellence for Behavioral Health in Nursing Facilities Grant

    [ad_1]

    Press Release


    Oct 18, 2022 16:45 EDT

    In September 2022, the Substance Abuse and Mental Health Services Administration (SAMHSA) awarded Alliant Health Solutions a three-year grant to establish a national center of excellence for building capacity in nursing facilities to care for residents with behavioral health conditions.

    The Center of Excellence for Behavioral Health in Nursing Facilities (COE-NF) will serve as a centralized hub and national model for expanding capacity in nursing facilities to care for residents with a variety of behavioral health needs. The program will support resource development and dissemination to better serve residents with Serious Mental Illness (SMI), Serious Emotional Disturbance (SED), Substance Use Disorders (SUD), or Co-occurring Disorders (COD). Training, technical assistance, and workforce development will be provided for staff in nursing facilities. 

    SAMHSA expects that this program will help to: (1) strengthen and sustain effective behavioral health practices and achieve better outcomes for nursing home residents with SMI, SED, SUD, or COD; and (2) ensure the availability of evidence-based training and technical assistance addressing mental health disorder identification, treatment, and recovery support services. Training and technical assistance will also be provided to support facilities in improving care for this population.

    “Alliant recognizes that mental health is an important part of someone’s overall health and well-being. Our support for the Center of Excellence Nursing Facility will provide necessary resources to support the nursing facility residents that have been diagnosed with behavioral health needs and will also increase awareness about how mental health and substance use affects millions of people and their families nationwide,” says Dennis White, President and CEO at Alliant Health Solutions.

    For more information about the Center of Excellence Nursing Facility, visit https://bit.ly/COE_BH_NursingFacility or contact Alliant Health Solutions at COEinfo@allianthealth.org.

    Source: Alliant Health Solutions

    [ad_2]

    Source link

  • These 11 stocks can lead your portfolio’s rebound after the S&P 500 ‘earnings recession’ and a market bottom next year

    These 11 stocks can lead your portfolio’s rebound after the S&P 500 ‘earnings recession’ and a market bottom next year

    [ad_1]

    This may surprise you: Wall Street analysts expect earnings for the S&P 500 to increase 8% during 2023, despite all the buzz about a possible recession as the Federal Reserve tightens monetary policy to quell inflation.

    Ken Laudan, a portfolio manager at Kornitzer Capital Management in Mission, Kan., isn’t buying it. He expects an “earnings recession” for the S&P 500
    SPX,
    +2.78%

    — that is, a decline in profits of around 10%. But he also expects that decline to set up a bottom for the stock market.

    Laudan’s predictions for the S&P 500 ‘earnings recession’ and bottom

    Laudan, who manages the $83 million Buffalo Large Cap Fund
    BUFEX,
    -2.86%

    and co-manages the $905 million Buffalo Discovery Fund
    BUFTX,
    -2.82%
    ,
    said during an interview: “It is not unusual to see a 20% hit [to earnings] in a modest recession. Margins have peaked.”

    The consensus among analysts polled by FactSet is for weighted aggregate earnings for the S&P 500 to total $238.23 a share in 2023, which would be an 8% increase from the current 2022 EPS estimate of $220.63.

    Laudan said his base case for 2023 is for earnings of about $195 to $200 a share and for that decline in earnings (about 9% to 12% from the current consensus estimate for 2022) to be “coupled with an economic recession of some sort.”

    He expects the Wall Street estimates to come down, and said that “once Street estimates get to $205 or $210, I think stocks will take off.”

    He went further, saying “things get really interesting at 3200 or 3300 on the S&P.” The S&P 500 closed at 3583.07 on Oct. 14, a decline of 24.8% for 2022, excluding dividends.

    Laudan said the Buffalo Large Cap Fund was about 7% in cash, as he was keeping some powder dry for stock purchases at lower prices, adding that he has been “fairly defensive” since October 2021 and was continuing to focus on “steady dividend-paying companies with strong balance sheets.”

    Leaders for the stock market’s recovery

    After the market hits bottom, Laudan expects a recovery for stocks to begin next year, as “valuations will discount and respond more quickly than the earnings will.”

    He expects “long-duration technology growth stocks” to lead the rally, because “they got hit first.” When asked if Nvidia Corp.
    NVDA,
    +6.14%

    and Advanced Micro Devices Inc.
    AMD,
    +3.69%

    were good examples, in light of the broad decline for semiconductor stocks and because both are held by the Buffalo Large Cap Fund, Laudan said: “They led us down and they will bounce first.”

    Laudan said his “largest tech holding” is ASML Holding N.V.
    ASML,
    +3.79%
    ,
    which provides equipment and systems used to fabricate computer chips.

    Among the largest tech-oriented companies, the Buffalo Large Cap fund also holds shares of Apple Inc.
    AAPL,
    +3.09%
    ,
    Microsoft Corp.
    MSFT,
    +3.88%
    ,
    Amazon.com Inc.
    AMZN,
    +6.63%

    and Alphabet Inc.
    GOOG,
    +3.91%

    GOOGL,
    +3.73%
    .

    Laudan also said he had been “overweight’ in UnitedHealth Group Inc.
    UNH,
    +1.77%
    ,
    Danaher Corp.
    DHR,
    +2.64%

    and Linde PLC
    LIN,
    +2.25%

    recently and had taken advantage of the decline in Adobe Inc.’s
    ADBE,
    +2.32%

    price following the announcement of its $20 billion acquisition of Figma, by scooping up more shares.

    Summarizing the declines

    To illustrate what a brutal year it has been for semiconductor stocks, the iShares Semiconductor ETF
    SOXX,
    +2.12%
    ,
    which tracks the PHLX Semiconductor Index
    SOX,
    +2.29%

    of 30 U.S.-listed chip makers and related equipment manufacturers, has dropped 44% this year. Then again, SOXX had risen 38% over the past three years and 81% for five years, underlining the importance of long-term thinking for stock investors, even during this terrible bear market for this particular tech space.

    Here’s a summary of changes in stock prices (again, excluding dividends) and forward price-to-forward-earnings valuations during 2022 through Oct. 14 for every stock mentioned in this article. The stocks are sorted alphabetically:

    Company

    Ticker

    2022 price change

    Forward P/E

    Forward P/E as of Dec. 31, 2021

    Apple Inc.

    AAPL,
    +3.09%
    -22%

    22.2

    30.2

    Adobe Inc.

    ADBE,
    +2.32%
    -49%

    19.4

    40.5

    Amazon.com Inc.

    AMZN,
    +6.63%
    -36%

    62.1

    64.9

    Advanced Micro Devices Inc.

    AMD,
    +3.69%
    -61%

    14.7

    43.1

    ASML Holding N.V. ADR

    ASML,
    +3.79%
    -52%

    22.7

    41.2

    Danaher Corp.

    DHR,
    +2.64%
    -23%

    24.3

    32.1

    Alphabet Inc. Class C

    GOOG,
    +3.91%
    -33%

    17.5

    25.3

    Linde PLC

    LIN,
    +2.25%
    -21%

    22.2

    29.6

    Microsoft Corp.

    MSFT,
    +3.88%
    -32%

    22.5

    34.0

    Nvidia Corp.

    NVDA,
    +6.14%
    -62%

    28.9

    58.0

    UnitedHealth Group Inc.

    UNH,
    +1.77%
    2%

    21.5

    23.2

    Source: FactSet

    You can click on the tickers for more about each company. Click here for Tomi Kilgore’s detailed guide to the wealth of information available free on the MarketWatch quote page.

    The forward P/E ratio for the S&P 500 declined to 16.9 as of the close on Oct. 14 from 24.5 at the end of 2021, while the forward P/E for SOXX declined to 13.2 from 27.1.

    Don’t miss: This is how high interest rates might rise, and what could scare the Federal Reserve into a policy pivot

    [ad_2]

    Source link

  • CDC identifies new COVID variants that accounted for 11.4% of new cases in week ending Oct. 15

    CDC identifies new COVID variants that accounted for 11.4% of new cases in week ending Oct. 15

    [ad_1]

    The Centers for Disease Control and Prevention said a new COVID variant dubbed BQ.1 and a descendant called BQ.1.1 have gained traction in the U.S., accounting for 11.4% of new cases across the nation in the week ending Oct. 15.

    The two variants are lineages of BA.5, the omicron subvariant that remains dominant but has shrunk to account for just 67.9% of circulating variants, the agency said in a Friday update. The CDC had previously combined BQ.1 and BQ.1.1 with BA.5 cases because the numbers of the new variants were so small. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places.

    New York and New Jersey currently have the highest proportion of BQ.1 and BQ.1.1 infections, at about 20% of overall cases, according to CDC estimates.

    “When you get variants like that, you look at what their rate of increase is as a relative proportion of the variants, and this has a pretty troublesome doubling time,” Anthony Fauci, President Joe Biden’s chief medical adviser, said in an interview with CBS News. 

    Adding to concerns, the variant seems “to elude important monoclonal antibodies,” he added.

    Fauci is confident that Moderna
    MRNA,
    +3.92%
    ,
    as well as Pfizer
    PFE,
    +1.84%

    and German partner BioNTech
    BNTX,
    +2.45%
    ,
    will be able to update boosters to target the new subvariant. “The somewhat encouraging news is that it’s a BA.5 sublineage, so there are almost certainly going to be some cross-protections that you can boost up,” he said.

    So far, only 14.8 million people living in the U.S. have taken advantage of the new bivalent boosters that were authorized by the Food and Drug Administration in late August. That’s equal to about 7% of the 209 million who were initially eligible.

    The FDA authorized the Pfizer booster for use in people aged 12 and older and the Moderna booster for adults aged 18 and older. Last week, the FDA added children aged 5 to 11 to the Pfizer program and children aged 6 through 17 to the Moderna one.

    Experts are concerned that the low number of vaccinations is due to a sense that the pandemic is over and no longer poses a major risk for most people. U.S. cases are steadily declining and now stand at their lowest level since mid-April; however, the true tally is likely higher than the official count, because many people are testing at home, where data are not being collected.

    The daily average for new cases stood at 37,649 on Sunday, down 19% from two weeks ago, according to a New York Times tracker.

    The daily average for hospitalizations was down 5% to 26,475, while the daily average for deaths was down 8% to 374.

    But cold weather is expected to bring a new wave of cases, and hospitalizations are rising again in much of the Northeast, the Times tracker is showing.

    “That’s the thing that’s so frustrating for me and for my colleagues who are involved in this, is that we have the capability of mitigating against this. And the uptake of the new bivalent vaccine is not nearly as high as we would like it to be,” said Fauci.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Moderna and Gavi, the Vaccine Alliance, which is supplying vaccines to low- and middle-income countries, have agreed to cancel remaining orders under their 2022 COVID-19 vaccine agreement given “sufficient supply.” The biotechnology company has supplied Gavi with nearly 70 million doses of COVID-19 vaccines, in addition to facilitating the donation of more than 100 million doses. Moderna and Gavi said they will create a new framework that enables Gavi to buy up to 100 million COVID-19 vaccine doses in 2023. 

    • The World Health Organization, the Food and Agriculture Organization of the United Nations, the United Nations Environment Program and the World Organization for Animal Health on Monday launched a new initiative that aims to address health threats to humans, animals, plants and the environment. The One Health Joint Plan of Action “aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats,” the four agencies said in a statement.

    • China is doubling down on its zero-COVID strategy as a historic Communist Party congress opens in Beijing, BBC News reported. Zero COVID was a “people’s war to stop the spread of the virus,” said President Xi Jinping as he kicked off the meeting. There is increasing public fatigue over lockdowns and travel restrictions, and Beijing has come under strict security measures ahead of the congress, sparking frustration in the city, including a rare and dramatic public protest on Thursday criticizing Xi and his strategy.

    In a rare display of defiance, two banners were unfurled from a highway overpass in Beijing condemning Chinese President Xi Jinping and his strict COVID-19 policies. The protest took place days before the expected extension of Xi’s tenure.

    • Airline stocks rallied Monday after data showed that on Sunday, more people flew than on any other day since before the pandemic. Data from the Transportation Security Administration showed that 2.495 million travelers went through TSA checkpoints on Sunday, which is just above the previous 2022 high of 2.490 million on July 1 and the most since Feb. 11, 2020, which was exactly one month before the World Health Organization declared COVID-19 a global pandemic. In comparison, the day with the fewest travelers since the start of the pandemic was April 12, 2022, with 87,534 people traveling. And in 2019, there were 116 days of more travelers than Sunday, while the average for that year was 2.306 million. The U.S. Global Jets ETF
    JETS,
    +2.02%

     was up 2.2%.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 624.7 million on Monday, while the death toll rose above 6.56 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 96.9 million cases and 1,065,118 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.2 million people living in the U.S., equal to 68.1% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 110.8 million have had a booster, equal to 49% of the vaccinated population, and 25.6 million of those who are eligible for a second booster have had one, equal to 39% of those who received a first booster.

    [ad_2]

    Source link

  • Computers May Have Cracked the Code to Diagnosing Sepsis

    Computers May Have Cracked the Code to Diagnosing Sepsis

    [ad_1]

    This article was originally published in Undark Magazine.

    Ten years ago, 12-year-old Rory Staunton dove for a ball in gym class and scraped his arm. He woke up the next day with a 104-degree Fahrenheit fever, so his parents took him to the pediatrician and eventually the emergency room. It was just the stomach flu, they were told. Three days later, Rory died of sepsis after bacteria from the scrape infiltrated his blood and triggered organ failure.

    “How does that happen in a modern society?” his father, Ciaran Staunton, asked me.

    Each year in the United States, sepsis kills more than a quarter million people—more than stroke, diabetes, or lung cancer. One reason for all this carnage is that if sepsis is not detected in time, it’s essentially a death sentence. Consequently, much research has focused on catching sepsis early, but the condition’s complexity has plagued existing clinical support systems—electronic tools that use pop-up alerts to improve patient care—with low accuracy and high rates of false alarm.

    That may soon change. Back in July, Johns Hopkins researchers published a trio of studies in Nature Medicine and npj Digital Medicine showcasing an early-warning system that uses artificial intelligence. The system caught 82 percent of sepsis cases and significantly reduced mortality. While AI—in this case, machine learning—has long promised to improve health care, most studies demonstrating its benefits have been conducted using historical data sets. Sources told me that, to the best of their knowledge, when used on patients in real time, no AI algorithm has shown success at scale. Suchi Saria, the director of the Machine Learning and Healthcare Lab at Johns Hopkins University and the senior author of the studies, said in an interview that the novelty of this research is how “AI is implemented at the bedside, used by thousands of providers, and where we’re seeing lives saved.”

    The Targeted Real-Time Early Warning System scans through hospitals’ electronic health records—digital versions of patients’ medical histories—to identify clinical signs that predict sepsis, alert providers about at-risk patients, and facilitate early treatment. Leveraging vast amounts of data, TREWS provides real-time patient insights and a unique level of transparency in its reasoning, according to the Johns Hopkins internal-medicine physician Albert Wu, a co-author of the study.

    Wu says that this system also offers a glimpse into a new age of medical electronization. Since their introduction in the 1960s, electronic health records have reshaped how physicians document clinical information; nowadays, however, these systems primarily serve as “an electronic notepad,” he added. With a series of machine-learning projects on the horizon, both from Johns Hopkins and other groups, Saria says that using electronic records in new ways could transform health-care delivery, providing physicians with an extra set of eyes and ears—and helping them make better decisions.

    It’s an enticing vision, but one in which Saria, the CEO of the company developing TREWS, has a financial stake. This vision also discounts the difficulties of implementing any new medical technology: Providers might be reluctant to trust machine-learning tools, and these systems might not work as well outside controlled research settings. Electronic health records also come with many existing problems, from burying providers under administrative work to risking patient safety because of software glitches.

    Saria is nevertheless optimistic. “The technology exists; the data is there,” she says. “We really need high-quality care-augmentation tools that will allow providers to do more with less.”


    Currently, there’s no single test for sepsis, so health-care providers have to piece together their diagnoses by reviewing a patient’s medical history, conducting a physical exam, running tests, and relying on their own clinical impressions. Given such complexity, over the past decade, doctors have increasingly leaned on electronic health records to help diagnose sepsis, mostly by employing a rules-based criteria—if this, then that.

    One such example, known as the SIRS criteria, says a patient is at risk of sepsis if two of four clinical signs—body temperature, heart rate, breathing rate, white-blood-cell count—are abnormal. This broadness, although helpful for catching the various ways sepsis might present itself, triggers countless false positives. Take a patient with a broken arm: “A computerized system might say, ‘Hey, look, fast heart rate, breathing fast.’ It might throw an alert,” says Cyrus Shariat, an ICU physician at Washington Hospital in California. The patient almost certainly doesn’t have sepsis but would nonetheless trip the alarm.

    These alerts also appear on providers’ computer screens as a pop-up, which forces them to stop whatever they’re doing to respond. So, despite these rules-based systems occasionally reducing mortality, there’s a risk of alert fatigue, where health-care workers start ignoring the flood of irritating reminders. According to M. Michael Shabot, a surgeon and the former chief clinical officer of Memorial Hermann Health System, “It’s like a fire alarm going off all the time. You tend to be desensitized. You don’t pay attention to it.”

    Already, electronic records aren’t particularly popular among doctors. In a 2018 survey, 71 percent of physicians said that the records greatly contribute to burnout, and 69 percent said that they take valuable time away from patients. Another 2016 study found that, for every hour spent on patient care, physicians have to devote two extra hours to electronic health records and desk work. James Adams, the chair of the Department of Emergency Medicine at Northwestern University, calls electronic health records a “congested morass of information.”

    But Adams also says that the health-care industry is at an inflection point to transform the files. An electronic record doesn’t have to simply involve a doctor or nurse putting data in, he says; instead, it “needs to transform to be a clinical-care-delivery tool.” With their universal deployment and real-time patient data, electronic records could warn providers about sepsis and various other conditions—but that will require more than a rules-based approach.

    What doctors need, according to Shabot, is an algorithm that can integrate various streams of clinical information to offer a clearer, more accurate picture when something’s wrong.


    Machine-learning algorithms work by looking for patterns in data to predict a particular outcome, like a patient’s risk of sepsis. Researchers train the algorithms on existing data sets, which helps the algorithms create a model for how that world works and then make predictions on new data sets. The algorithms can also actively adapt and improve over time, without the interference of humans.

    TREWS follows this general mold. The researchers first trained the algorithm on historical electronic-records data so that it could recognize early signs of sepsis. After this testing showed that TREWS could have identified patients with sepsis hours before they actually got treatment, the algorithm was deployed inside hospitals to influence patient care in real time.

    Saria and Wu published three studies on TREWS. The first tried to determine how accurate the system was, whether providers would actually use it, and if use led to earlier sepsis treatment. The second went a step further to see if using TREWS actually reduced patient mortality. And the third interviewed 20 providers who tested the tool on what they thought about machine learning, including what factors facilitate versus hinder trust.

    In these studies, TREWS monitored patients in the emergency department and inpatient wards, scanning through their data—vital signs, lab results, medications, clinical histories, and provider notes—for early signals of sepsis. (Providers could do this themselves, Saria says, but it might take them about 20 to 40 minutes.) If the system suspected organ dysfunction based on its analysis of millions of other data points, it flagged the patient and prompted providers to confirm sepsis, dismiss the alert, or temporarily pause the alert.

    “This is a colleague telling you, based upon data and having reviewed all this person’s chart, why they believe there’s reason for concern,” Saria says. “We very much want our frontline providers to disagree, because they have ultimately their eyes on the patient.” And TREWS continuously learns from these providers’ feedback. Such real-time improvements, as well as the diversity of data TREWS considers, are what distinguish it from other electronic-records tools for sepsis.

    In addition to these functional differences, TREWS doesn’t alert providers with incessant pop-up boxes. Instead, the system uses a more passive approach, with alerts arriving as icons on the patient list that providers can click on later. Initially, Saria was worried this might be too passive: “Providers aren’t going to listen. They’re not going to agree. You’re mostly going to get ignored.” However, clinicians responded to 89 percent of the system’s alerts. One physician interviewed for the third study described TREWS as less “irritating” than the previous rules-based system.

    Saria says that TREWS’s high adoption rate shows that providers will trust AI tools. But Fei Wang, an associate professor of health informatics at Weill Cornell Medicine, is more skeptical about how these findings will hold up if TREWS is deployed more broadly. Although he calls these studies first-of-a-kind and thinks their results are encouraging, he notes that providers can be conservative and resistant to change: “It’s just not easy to convince physicians to use another tool they are not familiar with,” Wang says. Any new system is a burden until proven otherwise. Trust takes time.

    TREWS is further limited because it only knows what’s been inputted into the electronic health record—the system is not actually at the patient’s bedside. As one emergency-department physician put it, in an interview for the third study, the system “can’t help you with what it can’t see.” And even what it can see is filled with missing, faulty, and out-of-date data, according to Wang.

    But Saria says that TREWS’s strengths and limitations complement those of health-care providers. Although the algorithm can analyze massive amounts of clinical data in real time, it will always be limited by the quality and comprehensiveness of the electronic health record. The goal, Saria adds, is not to replace physicians, but to partner with them and augment their capabilities.


    The most impressive aspect of TREWS, according to Zachary Lipton, an assistant professor of machine learning and operations research at Carnegie Mellon University, is not the model’s novelty, but the effort it must have taken to deploy it on 590,736 patients across five hospitals over the course of the study. “In this area, there is a tremendous amount of offline research,” Lipton says, but relatively few studies “actually make it to the level of being deployed widely in a major health system.” It’s so difficult to perform research like this “in the wild,” he adds, because it requires collaborations across various disciplines, from product designers to systems engineers to administrators.

    As such, by demonstrating how well the algorithm worked in a large clinical study, TREWS has joined an exclusive club. But this uniqueness may be fleeting. Duke University’s Sepsis Watch algorithm, for one, is currently being tested across three hospitals following a successful pilot phase, with more data forthcoming. In contrast with TREWS, Sepsis Watch uses a type of machine learning called deep learning. Although this can provide more powerful insights, how the deep-learning algorithm comes to its conclusions is unexplainable—a situation that computer scientists call the black-box problem. The inputs and outputs are visible, but the process in between is impenetrable.

    On the one hand, there’s the question of whether this is really a problem: Doctors don’t always know how drugs work, Adams says, “but at some point, we have to trust what the medicine is doing.” Lithium, for example, is a widely used, effective treatment for bipolar disorder, but nobody really understands exactly how it works. If an AI system is similarly useful, maybe interpretability doesn’t matter.

    Wang suggests that that’s a dangerous conclusion. “How can you confidently say your algorithm is accurate?” he asks. After all, it’s difficult to know anything for sure when a model’s mechanics are a black box. That’s why TREWS, a simpler algorithm that can explain itself, might be a more promising approach. “If you have this set of rules,” Wang says, “people can easily validate that everywhere.”

    Indeed, providers trusted TREWS largely because they could see descriptions of the system’s process. Of the clinicians interviewed, none fully understood machine learning, but that level of comprehension wasn’t necessary.


    In machine learning, although the specific algorithmic design is important, the results have to speak for themselves. By catching 82 percent of sepsis cases and reducing time to antibiotics by 1.85 hours, TREWS ultimately reduced patient deaths. “This tool is, No. 1, very good; No. 2, received well by clinicians; and No. 3, impacts mortality,” Adams says. “That combination makes it very special.”

    However, Shariat, the ICU physician at Washington Hospital in California, was more cautious about these findings. For one, these studies only compared patients with sepsis who had the TREWS alert confirmed within three hours to those who didn’t. “They’re just telling us that this alert system that we’re studying is more effective if someone responds to it,” Shariat says. A more robust approach would have been to conduct a randomized controlled trial—the gold standard of medical research—where half of patients got TREWS in their electronic record while the other half didn’t. Saria says that randomization would have been difficult to do given patient-safety concerns, and Shariat agrees. Even so, he says that the absence “makes the data less rigorous.”

    Shariat also worries that the sheer volume of alerts, with about two out of three being false positives, might contribute to alert fatigue—and potentially overtreatment with fluids and antibiotics, which can lead to serious medical complications such as pulmonary edema and antibiotic resistance. Saria acknowledges that TREWS’s false-positive rate, although lower than that of existing electronic-health-record systems, could certainly improve, but says it will always be crucial for clinicians to continue to use their own judgment.

    The studies also have a conflict of interest: Saria is entitled to revenue distribution from TREWS, as is Johns Hopkins. “If this goes prime time, and they sell it to every hospital, there’s so much money,” Shariat says. “It’s billions and billions of dollars.”

    Saria maintains that these studies went through rigorous internal and external review processes to manage conflicts of interest, and that the vast majority of study authors don’t have a financial stake in this research. Regardless, Shariat says it will be crucial to have independent validation to confirm these findings and ensure the system is truly generalizable.

    The Epic Sepsis Model, a widely used algorithm that scans through electronic records but doesn’t use machine learning, is a cautionary example here, according to David Bates, the chief of general internal medicine at Brigham and Women’s Hospital. He explains that the model was developed at a few health systems with promising results before being deployed at hundreds of others. The model then deteriorated, missing two-thirds of patients with sepsis and having a concerningly high false-positive rate. “You can’t really predict how much the performance is going to degrade,” Bates says, “without actually going and looking.”

    Despite the potential drawbacks, Orlaith Staunton, Rory’s mother, told me that TREWS could have saved her son’s life. “There was complete breakdown in my son’s situation,” she said; none of his clinicians considered sepsis until it was too late. An early-warning system that alerted them about the condition, she added, “would make the world of difference.”

    After Rory’s death, the Stauntons started the organization End Sepsis to ensure that no other family would have to go through their pain. In part because of their efforts, New York State mandated that hospitals develop sepsis protocols, and the CDC launched a sepsis-education campaign. But none of this will ever bring back Rory, Ciaran Staunton said: “We will never be happy again.”

    This research is personal for Saria as well. Almost a decade ago, her nephew died of sepsis. By the time it was discovered, there was nothing his doctors could do. “It all happened too quickly, and we lost him,” she says. That’s precisely why early detection is so important—life and death can be mere minutes away. “Last year, we flew helicopters on Mars,” Saria says, “but we’re still freaking killing patients every day.”

    [ad_2]

    Simar Bajaj

    Source link

  • Five takeaways from the Georgia Senate debate | CNN Politics

    Five takeaways from the Georgia Senate debate | CNN Politics

    [ad_1]



    CNN
     — 

    When Democratic Sen. Raphael Warnock and Republican Herschel Walker met to debate in the already contentious Georgia Senate race, all the focus was on how personal allegations against Walker would roil the first – and likely only – debate in the campaign.

    The allegations that Walker paid for a woman to terminate her pregnancy and then, two years later, encouraged the same woman to have the procedure a second time, however, were just a blip in the hour-long contest, which instead centered on Warnock’s ties to President Joe Biden, the vast differences between the two candidates on abortion and even, however briefly, Walker’s use of what appeared to be a sheriff’s badge.

    Walker continued to deny the allegations about him – calling them “a lie” – and Warnock, as he has on the campaign trail, did not engage on the controversy, instead choosing to question his Republican opponent’s relationship to the truth.

    “We will see time and time again, as we have already seen, that my opponent has a problem with the truth,” Warnock said. “And just because he says something doesn’t mean it’s true.”

    For Walker, the debate was as much about touting his own candidacy as it was about tying Warnock to Biden, who was invoked early and often. His effort, in the closing moments, to assuage fence-sitting voters about his readiness to serve also included a jab at Warnock and Biden.

    “For those of you who are concerned about voting for me, a non-politician, I want you to think about the damage politicians like Joe Biden and Raphael Warnock have done to this country,” Walker said.

    Here are five takeaways from Friday’s debate:

    Biden wasn’t on the stage Friday night, but Walker tried repeatedly to convince viewers that the Democratic President was ostensibly there with his Democratic opponent.

    From the outset of the event, Walker repeatedly invoked Biden, hoping to tie his Democratic opponent to the President’s low approval ratings.

    “This race isn’t about me. It is about what Raphael Warnock and Joe Biden have done to you and your family,” Walker said at the top of the debate.

    Later, when pressed on voter fraud in the 2020 election, he added, “Did President Biden win? President Biden won, and Sen. Warnock won. That’s the reason I decided to run.”

    He then synthesized his point: “I am running because he and Joe Biden are the same.”

    Warnock did little to distance himself from Biden, even at times touting the legislation he passed with the President’s help. But during a question on foreign policy, he took the chance to note a specific time he stood up to the Biden administration.

    “I am glad we are standing up to Putin’s aggression and we have to continue to stand up, which is why I stood up to the Biden administration when it suggested we should close the Savanah Combat Readiness Training Center,” Warnock said. “I told the President that was the exact wrong thing to do at the exact wrong time. … We kept that training center open.”

    Walker went back to his message in response: “He didn’t stand up. He had laid down every time it came around.”

    “It is evident,” said a somewhat exasperated Warnock, “that he has a point that he tried to make time and time again.”

    Headed into the debate, the focus was on how Walker – and arguably less predictably, Warnock – would address the accusations that the Republican candidate allegedly paid for a woman to terminate her pregnancy and then, two years later, encouraged the same woman to have the procedure a second time.

    Walker did what he has done repeatedly as the allegations roiled an already contentious Senate race: Label the allegations a lie.

    “As I said, that is a lie,” Walker said in response to a question from the moderator. “I put it in a book, one thing about my life, I have been very transparent. Not like the senator, he has hid things.”

    Walker added: “I said that is a lie and I am not backing down. And we have Sen. Warnock, people that would do anything and say anything for this seat. But I am not going to back down.”

    CNN has not independently verified the allegations about Walker.

    Warnock, as he has done previously, did not address the allegations, instead choosing to let Walker fight them off without pushing them himself.

    Instead, the senator took a broad approach, focusing on Walker’s “problem with the truth” and less on the specific allegations.

    The candidates also clashed on abortion rights more generally, with Walker insisting he did not support a federal ban, in contrast to past statements, and pointing to the state’s restrictive “heartbeat” law. The law prohibits abortions as soon as early cardiac activity is detectable, which can be as early as six weeks, before many women know they are pregnant.

    “On abortion, I’m a Christian. I believe in life. Georgia is a state that respects life,” Walker said.

    The Georgia law makes exceptions for cases of rape or incest, pending a timely police report, and in some cases where the pregnant person’s health is at risk.

    Before the Supreme Court’s ruling overturning Roe v. Wade, state law had allowed abortions up to 20 weeks.

    Warnock, who supports abortion rights, repeated an argument he’s made on the trail: “A patient’s room is too narrow and small and cramped for a woman, her doctor and the US government. … I trust women more than I trust politicians.”

    Walker then shot back, invoking Warnock’s support for the Black Lives Matter movement against police brutality.

    “He told me Black lives matter… If Black lives matter, why are you not protecting those babies? And instead of aborting those babies, why aren’t you baptizing those babies?,” Walker said.

    Warnock, as he did throughout the debate, didn’t directly answer Walker’s provocation. Instead, he repeated his position.

    “There are enough politicians piling into the rooms of patients,” the senator said, “and I don’t plan to join them.”

    Georgia is one of 12 states not to expand Medicaid and currently has an estimated 1.5 million uninsured residents.

    Walker, when asked by the moderator if the federal government should step in to make sure everyone has access to health care, began a confusing non-response.

    “Well, right now, people have coverage for health care. It’s according to what type of coverage do you want. Because if you have an able-bodied job, you’re going to have health care,” he said. “But everyone else – have health care is the type of health care you’re going to get. And I think that is the problem.”

    Walker continued to say that Warnock wants people to “depend on the government,” while he wants “you to get off the government health care and get on the health care he’s got.”

    To note: Warnock, as a US Senator, is on a government health care plan.

    Walker also gave a puzzling response to Warnock’s attack on his opposition to federal legislation capping the price of insulin for people with diabetes.

    “I believe in reducing insulin, but at the same time, you have to eat right,” Walker said. “Unless you have eating right, insulin is doing you no good. So you have to get food prices down and you got to get gas prices down so they can go and get insulin.”

    Warnock responded by telling viewers who require the drug that Walker was, in effect, blaming them for their struggles accessing it.

    Warnock, on the subject of his pledge to close the Medicaid gap, was asked how he would pay for it.

    “This is not a theoretical issue for me,” he replied, invoking the story of a nurse in a trauma ward who lost coverage when she became sick and, as he put it, died “for lack of health care.”

    “Georgia needs to expand Medicaid,” Warnock continued. “It costs us more not to expand. What we’re doing right now is we’re subsidizing health care in other states” – a reference to the state’s refusal to accept federal funds that residents already pay into.

    The debate within the debate over Warnock’s support for police, in which the senator pointed to his support for legislation that backed smaller departments, was briefly derailed when Walker pulled out what appeared to be a police badge.

    The moderator quickly admonished Walker, reminding him that props were not allowed onstage.

    “You have a prop,” the surprised moderator said. “That is not allowed, sir.”

    Moments earlier, Warnock – in response to Walker’s claims that he has “called (police officers) names” and caused “morale” to plummet – said that his opponent “has a problem with the truth.”

    Warnock then hit Walker with a callback to a more than two-decade-old police report in which the Republican discussed exchanging gunfire with police and a subsequent false claim from Walker that he previously served in law enforcement.

    “One thing that I haven’t done is I haven’t pretended to be a police officer and I’ve never, ever threatened a shootout with police,” he said.

    Warnock also argued that his support for greater scrutiny of police didn’t undermine his support for law enforcement.

    “You can support police officers, as I’ve done, through the COPS program, through the invest-to-protect program, while at the same time, holding police officers, like all professions, accountable,” he said.

    [ad_2]

    Source link

  • Study finds Paxlovid can interact badly with some heart medications, and White House renews COVID emergency through Jan. 11

    Study finds Paxlovid can interact badly with some heart medications, and White House renews COVID emergency through Jan. 11

    [ad_1]

    A new study has found that the COVID antiviral Paxlovid can interact badly with certain heart medications, raising concerns for patients with cardiovascular risk who test positive.

    The study was published in the Journal of the American College of Cardiology and found the reaction involved such medications as blood thinners and statins. As patients who are hospitalized with COVID are at elevated risk of heart problems, they are likely to be described Paxlovid, which was developed by Pfizer
    PFE,
    -0.45%
    .

     “Co-administration of NMVr (Paxlovid) with medications commonly used to manage cardiovascular conditions can potentially cause significant drug-drug interactions and may lead to severe adverse effects,” the authors wrote. “It is crucial to be aware of such interactions and take appropriate measures to avoid them.”

    The news comes just days after the White House made a renewed push to encourage Americans above the age of 50 to take Paxlovid or use monoclonal antibodies if they test positive and are at risk of developing severe disease.

    White House coordinator Dr. Ashish Jha told the New York Times that greater use of the medicine could reduce the average daily death count to about 50 a day from close to 400 currently.

    “I think almost everybody benefits from Paxlovid,” Jha said. “For some people, the benefit is tiny. For others, the benefit is massive.” 

    Yet a smaller share of 80-year-olds with COVID in the U.S. is taking it than 45-year-olds, Jha said, citing data said he has seen.

    On Thursday, the White House extended its COVID pubic health emergency through Jan. 11 as it prepares for an expected rise in cases in the colder months, the Associated Press reported.

    The public health emergency, first declared in January 2020 and renewed every 90 days since, has dramatically changed how health services are delivered.

    The declaration enabled the emergency authorization of COVID vaccines, as well as free testing and treatments. It expanded Medicaid coverage to millions of people, many of whom will risk losing that coverage once the emergency ends. It temporarily opened up telehealth access for Medicare recipients, enabling doctors to collect the same rates for those visits and encouraging health networks to adopt telehealth technology.

    Since the beginning of this year, Republicans have pressed the administration to end the public health emergency.

    President Joe Biden, meanwhile, has urged Congress to provide billions more in aid to pay for vaccines and testing. Amid Republican opposition to that request, the federal government ceased sending free COVID tests in the mail last month, saying it had run out of funds for that effort.

    Separately, the head of the World Health Organization urged countries to continue to surveil, monitor and track COVID and to ensure poorer countries get access to vaccines, diagnostics and treatments, reiterating that the pandemic is not yet over.

    Tedros Adhanom Ghebreyesus said most countries no longer have measures in place to limit the spread of the virus, even though cases are rising again in places including Europe.

    “Most countries have reduced surveillance drastically, while testing and sequencing rates are also much lower,” Tedros said in opening remarks at the IHR Emergency Committee on COVID-19 Pandemic on Thursday.

    “This,” said the WHO leader, “is blinding us to the evolution of the virus and the impact of current and future variants.”

    U.S. known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people overall are testing at home, where the data are not being collected.

    The daily average for new cases stood at 38,530 on Thursday, according to a New York Times tracker, down 19% from two weeks ago. Cases are rising in six states, namely Nevada, New Mexico, Kansas, Maine, Wisconsin and Vermont, and are flat in Wyoming. They are falling everywhere else.

    The daily average for hospitalizations was down 7% at 26,665, while the daily average for deaths is down 7% to 377. 

    The new bivalent vaccine might be the first step in developing annual Covid shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to Covid could be challenging. Illustration: Ryan Trefes

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Federal Health Minister Karl Lauterbach has urged German states to reintroduce face-mask requirements for indoor spaces due to high COVID cases numbers, the Local.de reported. Lauterbach was launching his ministry’s new COVID campaign on Friday. “The direction we are heading in is not a good one,” he said at a press conference in Berlin, adding it’s better to take smaller measures now than be forced into drastic ones later.

    • Health officials in Washington and Oregon said Thursday that a fall and winter COVID surge is likely headed to the Pacific Northwest after months of relatively low case levels, the AP reported. King County (Wash.) Health Officer Dr. Jeff Duchin said during a news briefing that virus trends in Europe show a concerning picture of what the U.S. could soon see, the Seattle Times reported.

    Two banners unfurled from a highway overpass in Beijing condemned Chinese President Xi Jinping and his strict Covid policies, in a rare display of defiance. The protest took place days before the expected extension of the leader’s tenure.

    • Kevin Spacey’s trial on sexual-misconduct allegations will continue without a lawyer who tested positive for COVID on Thursday, Yahoo News reported. The “American Beauty” and “House of Cards” star is on trial in Manhattan federal court facing allegations in a $40 million civil lawsuit that he preyed upon actor Anthony Rapp in 1986 when Rapp was 14 and Spacey was 26. Jennifer Keller’s diagnosis comes after she spent about five hours cross-examining Rapp on the witness stand over two days — a few feet away from the jury box without wearing a mask.

    • A man who presents himself as an Orthodox Christian monk and an attorney with whom he lived fraudulently obtained $3.5 million in federal pandemic relief funds for nonprofit religious organizations and related businesses they controlled, and spent some of it to fund a “lavish lifestyle,” federal prosecutors said Thursday. Brian Andrew Bushell, 47, and Tracey M.A. Stockton, 64, are charged with conspiracy to commit wire fraud and unlawful monetary transactions, the U.S. attorney’s office in Boston said in a statement, as reported by the AP.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 623.9 million on Monday, while the death toll rose above 6.56 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 96.9 million cases and 1,064,821 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.2 million people living in the U.S., equal to 68.1% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 110.8 million have had a booster, equal to 49% of the vaccinated population, and 25.6 million of those who are eligible for a second booster have had one, equal to 39% of those who received a first booster.

    Some 14.8 million people have had a shot of the new bivalent booster that targets the new omicron subvariants.

    [ad_2]

    Source link

  • First They Get Long COVID, Then They Lose Their Health Care

    First They Get Long COVID, Then They Lose Their Health Care

    [ad_1]

    Oct. 13, 2022 – It’s a devastating series of setbacks for long COVID patients. First, they get the debilitating symptoms of their condition. Then they are forced to give up their jobs, or severely curtail their work hours, as their symptoms linger. And next, for many, they lose their employer-sponsored health insurance. 

    While not all long COVID patients are debilitated, the CDC’s ongoing survey on long COVID found a quarter of adults with long COVID report it significantly affects their day-to-day living activities.

    Estimates have shown that long COVID has impacted the lives of anywhere from 16 million to 34 million Americans between the ages of 18 and 65. 

    While hard data is still limited, a Kaiser Family Foundation analysis found that more than half of adults with long COVID who worked before getting the virus are now either out of work or working fewer hours. 

    According to data from the Census Bureau’s Household Pulse Survey, out of the estimated 16 million working-age adults who currently have long COVID, 2 million to 4 million of them are out of work due to their symptoms. The cost of those lost wages ranges from $170 billion a year to as much as $230 billion, the Census Bureau says. And given that approximately 155 million Americans have employer-sponsored health insurance, the welfare of working-age adults may be under serious threat. 

    “Millions of people are now impacted by long COVID, and oftentimes along with that comes the inability to work,” says Megan Cole Brahim, PhD, an assistant professor in the Department of Health Law, Policy, and Management at Boston University and co-director of the school’s Medicaid Policy Lab. “And because a lot of people get their health insurance coverage through employer-sponsored coverage, no longer being able to work means you may not have access to the health insurance that you once had.”

    The CDC defines long COVID as a wide array of health conditions, including malaise, fatigue, shortness of breath, mental health issues, problems with the part of the nervous system that controls body functions, and more

    Gwen Bishop was working remotely for the Human Resources Department at the University of Washington Medical Centers when she got COVID-19. When the infection passed, Bishop, 39, thought she’d start feeling well enough to get back to work – but that didn’t happen. 

    “When I would log in to work and just try to read emails,” she says, “it was like they were written in Greek. It made no sense and was incredibly stressful.” . 

    This falls in line with what researchers have found out about the nervous system issues reported by people with long COVID. People who have survived acute COVID infections have reported lasting sensory and motor function problems, brain fog, and memory problems. 

    Bishop, who was diagnosed with ADHD when she was in grade school, says another complication she got from her long COVID was a new intolerance to stimulants like coffee and her ADHD medication, Vyvanse, which were normal parts of her everyday life. 

    “Every time I would take my ADHD medicine or have a cup of coffee, I would have a panic attack until it wore off,” says Bishop. “Vyvanse is a very long-acting stimulant, so that would be an entire day of an endless panic attack.” 

    In order for her to get a medical leave approved, Bishop needed to get documents by a certain date from her doctor’s office that confirmed her long COVID diagnosis. She was able to get a couple of extensions, but Bishop says that with the burden that has been placed on our medical systems, getting in to see a doctor through her employer insurance was taking much longer than expected. By the time she got an appointment, she says, she had already been fired for missing too much work. Emails she provided showing exchanges between her and her employer verify her story. And without her health insurance, her appointment through that provider would no longer have been covered.

    In July 2021, the U.S. Department of Health and Human Services issued guidance recognizing long COVID as a disability “if the person’s condition or any of its symptoms is a ‘physical or mental’ impairment that ‘substantially limits’ one or more major life activities.” 

    But getting access to disability benefits hasn’t been easy for people with long COVID. On top of having to be out of work for 12 months before being able to qualify for Social Security Disability Insurance, some of those who have applied say they have had to put up a fight to actually gain access to disability insurance. The Social Security Administration has yet to reveal just how many applications that cited long COVID have been denied so far.  

    David Barnett, a former bartender in the Seattle area in his early 40s, got COVID-19 in March 2020. Before his infection, he spent much of his time working on his feet, bodybuilding, and hiking with his partner. But for the last nearly 3 years, even just going for a walk has been a major challenge. He says he has spent much of his post-COVID life either chair-bound or bed-bound due to his symptoms. 

    He is currently on his partner’s health insurance plan but is still responsible for copays and out-of-network appointments and treatments. After being unable to bartend any more, he started a GoFundMe account and dug into his personal savings. He says he applied for food stamps and is getting ready to sell his truck. Barnett applied for disability in March of this year but says he was denied benefits by the Social Security Administration and has hired a lawyer to appeal.

    He runs a 24-hour online support group on Zoom for people with long COVID and says that no one in his close circle has successfully gotten access to disability payments. 

    Alba Azola, MD, co-director of Johns Hopkins School of Medicine’s Post-Acute COVID-19 Team, says at least half of her patients need some level of accommodations to get back to work; most can, if given the proper accommodations, such as switching to a job that can be done sitting down, or with limited time standing. But there are still patients who have been more severely disabled by their long COVID symptoms. 

    “Work is such a part of people’s identity. The people who are very impaired, all they want to do is to get back to work and their normal lives,” she says.

    Many of Azola’s long COVID patients aren’t able to return to their original jobs. She says they often have to find new positions more tailored to their new realities. One patient, a nurse and mother of five who previously worked in a facility where she got COVID-19, was out of work for 9 months after her infection. She ultimately lost her job, and Azola says the patient’s employer was hesitant to provide her with any accommodations. The patient was finally able to find a different job as a nurse coordinator where she doesn’t have to be standing for more than 10 minutes at a time.  

    Ge Bai, PhD, a professor of health policy and management at Johns Hopkins Bloomberg School of Public Health, says the novelty of long COVID and the continued uncertainty around it raise questions for health insurance providers. 

    “There’s no well-defined pathway to treat or cure this condition,” Bai says. “Right now, employers have discretion to determine when a condition is being covered or not being covered. So people with long COVID do have a risk that their treatments won’t be covered.” 

    [ad_2]

    Source link

  • Prosecutors ask jury to recommend death sentence for Parkland shooter | CNN

    Prosecutors ask jury to recommend death sentence for Parkland shooter | CNN

    [ad_1]



    CNN
     — 

    Prosecutors have called on a Florida jury to recommend the Parkland school shooter be put to death, saying in a closing argument Tuesday he meticulously planned the February 2018 massacre, and that the facts of the case outweigh anything in his background that defense attorneys claim warrant a life sentence.

    “What he wanted to do, what his plan was and what he did, was to murder children at school and their caretakers,” lead prosecutor Michael Satz said of Nikolas Cruz, who pleaded guilty to 17 counts of murder and 17 counts of attempted murder for the shooting at Marjory Stoneman Douglas High School, in which 14 students and three school staff members were killed. “That’s what he wanted to do.”

    But Cruz “is a brain damaged, broken, mentally ill person, through no fault of his own,” defense attorney Melisa McNeill said in her own closing argument, pointing to the defense’s claim that Cruz’s mother used drugs and drank alcohol while his mother was pregnant with him, saying he was “poisoned” in her womb.

    “And in a civilized humane society, do we kill brain damaged, mentally ill, broken people?” McNeill asked Tuesday. “Do we? I hope not.”

    With closing arguments, the monthslong sentencing phase of Cruz’s trial is nearing its end, marking prosecutors’ last chance to convince the jury to recommend a death sentence and defense attorneys’ last opportunity to lobby for life in prison without parole.

    Prosecutors have argued Cruz’s decision to commit the deadliest mass shooting at an American high school was premeditated and calculated, while Cruz’s defense attorneys have offered evidence of a lifetime of struggles at home and in school.

    Each side was allotted two and a half hours to make their closing arguments.

    Jury deliberations are expected to begin Wednesday, during which time jurors will be sequestered, per Broward Circuit Judge Elizabeth Scherer.

    If they choose to recommend a death sentence, the jurors must be unanimous, or Cruz will receive life in prison without the possibility of parole. If the jury does recommend death, the final decision rests with Judge Scherer, who could choose to follow the recommendation or sentence Cruz to life.

    In his remarks, Satz outlined prosecutors’ reasoning, including the preparations Cruz made. For a “long time” prior to the shooting, Satz said, Cruz thought about carrying it out.

    Revisiting ground covered in the trial, the prosecutor said Cruz researched mass shootings and their perpetrators, including those at a music festival in Las Vegas; at a movie theater in Aurora, Colorado; at Virginia Tech; and at Colorado’s Columbine High School.

    Cruz modified his AR-15 to help improve his marksmanship; he accumulated ammunition and and magazines; and he searched online for information about how long it would take police to respond to a school shooting, Satz said.

    Then, the day of, Satz said, Cruz hid his tactical vest in a backpack and took an Uber to the school, wearing a Marjory Stoneman Douglas JROTC polo shirt to blend in. Based on his planning, he told the Uber driver to drop him off at a specific pedestrian gate, knowing it would be open soon before school let out.

    “All these details he thought of, and he did,” Satz said.

    Satz also detailed a narrative of the shooting, which he called a “systematic massacre,” recounting how the shooter killed or wounded each of his victims, whose families and loved ones filled the courtroom gallery. Prosecutors also showed jurors a video of the shooting, which was not shown to the public.

    Cruz, wearing a striped sweater and flanked by his public defenders, looked on expressionless, occasionally looking down at the table in front of him or talking to one of his attorneys.

    “The appropriate sentence for Nikolas Cruz is the death penalty,” Satz concluded.

    In her own statement, McNeill stressed to jurors that defense attorneys were not disputing that Cruz deserves to be punished for the shooting.

    “We are asking you to punish him and to punish him severely,” she said. “We are asking you to sentence him to prison for the rest of his life, where he will wait to die, either by natural causes or whatever else could possibly happen to him while he’s in prison.”

    The 14 slain students were: Alyssa Alhadeff, 14; Martin Duque Anguiano, 14; Nicholas Dworet, 17; Jaime Guttenberg, 14; Luke Hoyer, 15; Cara Loughran, 14; Gina Montalto, 14; Joaquin Oliver, 17; Alaina Petty, 14; Meadow Pollack, 18; Helena Ramsay, 17; Alex Schachter, 14; Carmen Schentrup, 16; and Peter Wang, 14.

    Geography teacher Scott Beigel, 35; wrestling coach Chris Hixon, 49; and assistant football coach Aaron Feis, 37, also were killed – each while running toward danger or trying to help students to safety.

    The lengthy trial – jury selection began six months ago, in early April – has seen prosecutors and defense attorneys present evidence of aggravating factors and mitigating circumstances, reasons Cruz should or should not be put to death.

    The state has pointed to seven aggravating factors, including that the killings were especially heinous, atrocious or cruel, as well as cold, calculated and premeditated, Satz said Tuesday. Other aggravating factors include the fact the defendant knowingly created a great risk of death to many people and that he disrupted a lawful government function – in this case, the running of a school.

    Together, these aggravating factors “outweigh any mitigation about anything about the defendant’s background or character,” Satz said.

    Satz rejected the mitigating circumstances presented during trial by the defense, including that Cruz’s mother smoked or used drugs while pregnant with him. Those factors would not turn someone into a mass murderer, Satz argued, adding it was the jury’s job to weigh the credibility of the defense witnesses who testified to those claims.

    Satz cast doubt on the defense’s other proposed mitigators. In response to a claim that Cruz has neurological or intellectual deficits, Satz pointed to the gunman’s ability to carefully research and prepare for the Parkland shooting.

    In response to claims Cruz was bullied by his peers, Satz argued Cruz was an aggressor, pointing to testimony that he walked around in high school with a swastika drawn on his backpack, along with the N-word and other explicit language.

    “Hate is not a mental disorder,” Satz said.

    During trial, prosecutors presented evidence showing the gunman spent months searching online for information about mass shootings and left behind social media comments sharing his express desire to “kill people,” while Google searches illustrated how he sought information about mass shootings. On YouTube, Cruz left comments like “Im going to be a professional school shooter,” and promised to “go on a killing rampage.”

    “What one writes,” Satz said, referencing Cruz’s online history Tuesday, “what one says, is a window to someone’s soul.”

    Public defenders assigned to represent Cruz have asked the jury to take into account his troubled history, from a dysfunctional family life to serious mental and developmental issues, contending he was born with fetal alcohol spectrum disorder.

    On Tuesday, McNeill reiterated the defense’s case, starting with one of the first witnesses called in August, Cruz’s older sister, Danielle Woodard. Woodard testified their mother, Brenda Woodard, used drugs and drank alcohol while pregnant with him.

    “Her brother, Nikolas Cruz never recovered from the drugs and the alcohol that Brenda put in her polluted womb,” McNeill said Tuesday.

    Several neighbors who knew Cruz when he lived with his late adoptive mother, Lynda Cruz, also testified about watching him grow up, McNeill reminded jurors Tuesday. They shared how they saw him behaving in ways they described as “strange” or “weird,” or saw him being bullied. One neighbor, McNeill said, had told jurors that “from the moment he set eyes on Nikolas, he could tell something was not right with him.”

    McNeill also revisited Cruz’s academic struggles throughout his childhood, recounting the “many people” – including educators and school counselors or psychologists – who testified they had concerns about his bad behavior or poor performance in school.

    Assistant Public Defender Melisa McNeill gives her closing argument in the trial of the Parkland shooter on Tuesday.

    Those struggles continued into adolescence, McNeill said: When he was 15 years old, Cruz’s skills in reading, writing and math were well below the levels they should have been. These academic struggles, along with his anxiety and depression, were indicators, McNeill said, of fetal alcohol spectrum disorder.

    Various counselors and psychiatrists also testified, McNeill reminded the jury, offering their observations from years of treating or interacting with Cruz. One, former Broward County school district counselor John Newnham, testified that while Lynda Cruz was a caring mother, after the death of her husband, she was “overwhelmed” and did not take advantage of the support available.

    This was a factor in Cruz’s failure to receive the proper help, McNeill told jurors Tuesday.

    “Everybody told you that Lynda never truly appreciated what was wrong with Nikolas … But the evidence has shown you that Lynda consistently minimized, enabled, ignored, excused, defended and ultimately lied to the very people that were trying to help Nikolas.”

    “Sometimes the people who deserve the least amount of compassion and grace and remorse are the ones who should get it,” she said.

    As part of the prosecution’s case, family members of the victims were given the opportunity this summer to take the stand and offer raw and emotional testimony about how Cruz’s actions had forever changed their lives. At one point, even members of Cruz’s defense team were brought to tears.

    “I feel I can’t truly be happy if I smile,” Max Schachter, the father of 14-year-old victim Alex Schachter, testified in August. “I know that behind that smile is the sharp realization that part of me will always be sad and miserable because Alex isn’t here.”

    The defense’s case came to an unexpected end last month when – having called just 26 of 80 planned witnesses – public defenders assigned to represent Cruz abruptly rested, leading the judge to admonish the team for what she said was unprofessionalism, resulting in a courtroom squabble between her and the defense (the jury was not present).

    Defense attorneys would later file a motion to disqualify the judge for her comments, arguing in part they suggested the judge was not impartial and Cruz’s right to a fair trial had been undermined. Prosecutors disagreed, writing “judicial comments, even of a critical or hostile nature, are not grounds for disqualification.”

    Scherer ultimately denied the motion.

    Prosecutors then presented their rebuttal, concluding last week following a three-day delay attributed to Hurricane Ian.

    Their case included footage of Cruz telling clinical neuropsychologist Dr. Robert Denney he chose to carry out the shooting on Valentine’s Day because he “felt like no one loved me, and I didn’t like Valentine’s Day and I wanted to ruin it for everyone.”

    Denney, who spent more than 400 hours with the gunman, testified for the prosecution that he concluded Cruz has borderline personality disorder and anti-social personality disorder.

    But Cruz did not meet the criteria for fetal alcohol spectrum disorder, as the defense has contended, Denney testified, accusing Cruz of “grossly exaggerating” his “psychiatric problems” in tests Denney administered.

    When read the list of names of the 17 people killed and asked if fetal alcohol spectrum disorder explained their murders, Denney responded “no” each time.

    Correction: An earlier version of this story misspelled the first name of defense attorney Melisa McNeill.

    [ad_2]

    Source link

  • Kyiv calls for air defenses as Putin brings his Syria tactics to Ukraine

    Kyiv calls for air defenses as Putin brings his Syria tactics to Ukraine

    [ad_1]

    Press play to listen to this article

    Russian President Vladimir Putin turned back to his bloody, destructive playbook from Syria with a barrage of rocket attacks against civilian targets across Ukraine on Monday, ramping up pressure on Western allies to supply Kyiv with the air defenses it has long sought.

    Monday’s rush-hour bombardment on the streets of Kyiv, Lviv, Dnipro, Zaporizhzhia and other regions came as little surprise, given that Putin had already signaled his willingness to switch to ever more brutal tactics by appointing Sergey Surovikin, the general who oversaw Russian forces in Syria on-and-off from 2017 to 2020, as commander of his struggling war effort in Ukraine.

    In a speech at an emergency meeting of his National Security Council on Monday, Putin claimed the strikes came in response to this weekend’s attack on the Kerch Bridge linking illegally occupied Crimea to Russia. Putin said Russia had deployed “high-precision, long-range weapons from the air, sea and land” to deliver “massive attacks on targets of Ukraine’s energy, military command and communications facilities.” He added that Russia would continue to dole out retribution if Ukraine continued to strike so-called “Russian” territory.

    Ukraine’s defense ministry said 75 missiles were launched, 41 of which were shot down.

    Moscow’s claims to precision attacks on strategic targets seemed to mask the fact that the aim was clearly to kill civilians, as the missiles struck the Shevchenkivskyi district in the heart of Kyiv during peak morning traffic. Pictures and footage taken by reporters and from security cameras show cars on fire; a crater beside a children’s playground in the Shevchenko Park and a pedestrian bridge destroyed.

    Ukrainian President Volodymyr Zelenskyy said on Telegram that Russia appeared to have two targets in its assault: energy facilities throughout the country — and Ukrainians going about their daily lives.

    “They want panic and chaos,” Zelenskyy said, in a video that appeared to have been shot on his cell phone on the streets of Kyiv. Monday’s attacks came at a time “especially chosen to cause as much damage as possible … Why such strikes exactly? The enemy wants us to be afraid, wants to make people run. But we can only run forward — and we demonstrate this on the battlefield. It will continue to be so.”

    Zelenskyy also renewed his appeals to the West to provide Ukraine with additional air defenses. Kyiv has been seeking this additional firepower for weeks, arguing that Russia is likely to try to knock out Ukraine’s energy and industrial infrastructure over the winter, and it has been disappointed by the slow response.

    In tweets, Zelenskyy said he had spoken with German Chancellor Olaf Scholz and his French counterpart Emmanuel Macron in the wake of the strikes on the capital and other cities. With Macron, Zelenskyy said: “We discussed the strengthening of our air defense, the need for a tough European and international reaction, as well as increased pressure on the Russian Federation.”

    Those discussions on air defense batteries are now likely to loom large at the U.S.-led Ukraine Defense Contact Group — also known as the Ramstein format — where senior defense officials from across the globe will gather in Brussels later this week.

    Ukraine’s Defense Minister Oleksii Reznikov said on Monday: “The best response to Russian missile terror is the supply of anti-aircraft and anti-missile systems to Ukraine — protect the sky over Ukraine! This will protect our cities and our people. This will protect the future of Europe. Evil must be punished.”

    The butcher of Syria takes over

    Surovikin was only announced as the new Russian commander for Ukraine on Saturday.

    The 55-year-old general, who before his promotion had been charged with leading Russia’s Southern Military District and Russian troops in Syria, has long been an infamous figure with a reputation for being ruthless.

    He was linked to the violent suppression of the anti-Soviet 1990 Dushanbe riots in Tajikistan, and was reportedly imprisoned (before being freed without charge) after soldiers under his command killed three protesters in Moscow during the failed coup against then Soviet President Mikhail Gorbachev in August 1991. In 1995, Surovikin received a suspended sentence (which was later overturned) for participating in the illegal arms trade. Surovikin also played a role in Russia’s second Chechen war, commanding the 42nd Guards Motorized Rifle Division.

    But Surovikin is best known — and most feared — for his command of Russian forces in Syria, where Moscow intervened to prop up Bashar al-Assad’s regime. Human Rights Watch, a non-governmental organization, listed Surovikin as one of the commanders “who may bear command responsibility” for human rights violations during the 2019-2020 offensive in Syria’s Idlib province, when Syrian and Russian forces launched dozens of air and ground attacks on civilian targets and infrastructure, striking homes, schools, health care facilities and markets.

    It was not the first time Russian forces were accused of war crimes in Syria. The Kremlin’s troops, working with Syrians, undertook a month-long bombing campaign of opposition-controlled territory in Aleppo in 2016, killing hundreds of civilians, including 90 children, with indiscriminate airstrikes, cluster munitions and incendiary weapons hitting civilian targets including medical facilities.

    Now, with Russian forces on the back foot in Ukraine and Putin’s full-throated rhetoric out of step with the situation on the ground in his war, Surovikin appears to be turning to his old tactic of inflicting massive damage on civilians in an attempt to turn the tide of the war.

    [ad_2]

    Zoya Sheftalovich

    Source link

  • Large number of U.S. COVID deaths could be prevented if patients would take Pfizer’s Paxlovid, White House coordinator warns

    Large number of U.S. COVID deaths could be prevented if patients would take Pfizer’s Paxlovid, White House coordinator warns

    [ad_1]

    A large number of U.S. COVID deaths could be prevented if patients would take Paxlovid, the antiviral developed by Pfizer
    PFE,
    -1.79%

    that helps reduce the risk of hospitalization and death, according to White House COVID coordinator Dr. Ashish Jha.

    Jha told the New York Times that the average daily death count could be reduced to about 50 a day from 400 currently, if every American aged 50 and above that tests positive for the virus took a course of either Paxlovid or used monoclonal antibodies.

     “The public doesn’t seem to understand that the evidence around hospitalization and deaths is really powerful,” Dr. Robert Wachter, chair of medicine at the University of California in San Francisco told the paper.

    The issue seems to be a combination of worry about certain issues that Paxlovid can cause, including a strange metallic taste and the potential for “rebound COVID,” where patients quickly become reinfected after the five-day course of pills has been completed. That happened to both President Joe Biden and first lady Jill Biden recently.

    The second reason is that many Americans — and Republicans, in particular — have refused to take COVID seriously and are not willing to take steps to reduce its impact. Trials have found Paxlovid to be effective across all age groups, but mostly among older patients. But as the COVID death rate for people under 50 is already close to zero, reducing it in a statistically significant way is difficult.

    See now: CDC scraps travel health notices as countries slow testing, and study confirms Republican-leaning counties suffered more COVID deaths than Democrat-leaning ones

    “I think almost everybody benefits from Paxlovid,” Jha said. “For some people, the benefit is tiny. For others, the benefit is massive.” 

    Yet a smaller share of 80-year-olds with COVID in the U.S. is taking it than 45-year-olds, Jha said citing data he has seen.

    From the CDC: Stay Up to Date with COVID-19 Vaccines Including Boosters

    The news comes as U.S. known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, with data generally not being collected.

    The daily average for new cases stood at 41,605 on Thursday, according to a New York Times tracker, down 25% from two weeks ago. Cases are declining in northeastern states including New York and New Jersey, while cases are rising in the western states Montana, Washington and Oregon.

    The daily average for hospitalizations was down 11% at 27,021, while the daily average for deaths is down 8% to 391.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Molnupiravir, the COVID pill developed by Merck
    MRK,
    +0.18%

    and privately held Ridgeback Therapeutics, produced mixed results in two recent studies, the companies said Thursday. Early data from a trial conducted in the U.K. by the University of Oxford found no evidence of a difference when molnupiravir was added to usual care in reducing hospitalizations and death. A second study conducted in Israel found a benefit in patients who were 65 and older, but no benefit for 40- to 60-year-olds.

    • Homelessness is surging in the U.S. again as pandemic programs that halted evictions are being phased out, the Associated Press reported. The overall number of homeless people in a federal report to be released in the coming months is expected to be higher than the 580,000 unhoused before the coronavirus outbreak, the National Alliance to End Homelessness said. The AP tallied results from city-by-city surveys conducted earlier this year and found the number of people without homes is up overall compared with 2020 in areas reporting results so far.

    • The idea was to have China in stable and tip-top shape when thousands of delegates gather in Beijing to usher in a historic third term in power for Xi Jinping, BBC News reported. However, the coronavirus is not playing nicely. In recent weeks, tens of millions of people have again been confined to their homes in lockdowns across 60 towns and cities, and this is bringing political pressure on the man who has become the most powerful Chinese figure since the first communist-era leader, Mao Zedong.

    Covid-19 lockdowns, corruption crackdowns and more have put China’s economy on a potential crash course. WSJ’s Dion Rabouin explains how China’s economic downturn could harm the U.S. and the rest of the world. Illustration: David Fang

    • A new COVID-19 wave appears to be brewing in Europe as cooler weather arrives, with public health experts warning that vaccine fatigue and confusion over types of available vaccines will likely limit booster uptake, Reuters reported. The omicron subvariants BA.4 and BA.5 that dominated this summer are still behind the majority of infections, but newer omicron subvariants are gaining ground. Hundreds of new forms of omicron are being tracked by scientists, the World Health Organization said this week.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 620.5 million on Friday, while the death toll rose above 6.55 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 96.6 million cases and 1,062,130 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 225.8 million people living in the U.S., equal to 68% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 110.5 million have had a booster, equal to 48.9% of the vaccinated population, and 24.8 million of those who are eligible for a second booster have had one, equal to 37.9% of those who received a first booster.

    Some 11.5 million people have had a shot of the new bivalent booster that targets the new omicron subvariants.

    [ad_2]

    Source link

  • U.S. risks prolonging pandemic if it doesn’t back WTO push to get vaccines and treatments to lower-income countries, lawmakers warn

    U.S. risks prolonging pandemic if it doesn’t back WTO push to get vaccines and treatments to lower-income countries, lawmakers warn

    [ad_1]

    The U.S. is at risk of prolonging the COVID pandemic if it fails to back an initiative that aims to get vaccines, diagnostics and treatments to lower-income countries, a congressional group has told President Joe Biden.

    In a letter to Biden from the group led by Earl Blumenauer, a Democrat from Oregon, the group urged him to back the World Trade Organization’s agreement in June to ease exports of lifesaving therapies.

    With more than 600 million shots in arms, 21,500 free testing sites, the ability to order at-home tests for free, and more treatments available now than at any point in the pandemic, the outlook in the United States is better than ever. Unfortunately, however, the prospect for many low-income countries is not so positive — putting the United States’ own success in jeopardy,” the lawmakers wrote.

    The letter was sent ahead of a meeting of the WTO council for trade-related aspects of IP rights that is due to kick off Thursday.

    The group noted that lower-income countries are facing a higher risk of severe illness, hospitalization and death as only a small percentage of their populations are vaccinated. Just 19% of people in those countries are vaccinated, compared with about 75% in high-income countries, according to the Multilateral Leaders Taskforce on COVID-19, a joint initiative of the International Monetary Fund, the World Bank, the World Health Organization and the WTO.

    U.S. known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, where the data are not being collected.

    The daily average for new cases stood at 43,149 on Wednesday, according to a New York Times tracker, down 23% from two weeks ago. Cases are rising in most northeastern states by 10% of more, while cases in the western states Montana, Washington and Oregon are rising.

    The daily average for hospitalizations was down 11% at 27,184, while the daily average for deaths is down 8% to 391. 

    The new bivalent vaccine might be the first step in developing annual Covid shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to Covid could be challenging. Illustration: Ryan Trefes

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • China’s huge Xinjiang region has been hit with sweeping COVID travel restrictions ahead of a key Communist Party congress later this month, the Associated Press reported. Trains and buses in and out of the region of 22 million people have been suspended, and passenger numbers on flights have been reduced to 75% of capacity in recent days, according to Chinese media reports. The region is home to minorities who have been forced into prison-like re-education centers to force them to renounce their religion, typically Islam, and allegedly subjected to human-rights abuses.

    • Five current or former Internal Revenue Service workers have been charged with fraud for illegally getting money from federal COVID-19 relief programs and using a total of $1 million for luxury items and personal trips, prosecutors said, the AP reported. The U.S. attorney’s office in Memphis said Tuesday that the five have been charged with wire fraud after they filed fake applications for the Paycheck Protection Program and the Economic Injury Disaster Loan Program, which were part of a federal stimulus package tied to the pandemic response in 2020.

    • Peloton Interactive Inc.
    PTON,
    +3.84%

    said it plans to cut about 500 jobs, roughly 12% of its remaining workforce, in the company’s fourth round of layoffs this year as the connected fitness-equipment maker tries to reverse mounting losses, the Wall Street Journal reported. After enjoying a strong run early on in the pandemic, Peloton has struggled since the start of the U.S. recovery, and CEO Barry McCarthy, who took over in February, said he is giving the unprofitable company another six months or so to significantly turn itself around and, if it fails, Peloton likely isn’t viable as a stand-alone company.

    Don’t missPeloton CEO says ‘naysayers’ are looking at the company’s $1.2 billion quarterly loss all wrong.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 619.9 million on Wednesday, while the death toll rose above 6.55 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 96.6 million cases and 1,061,490 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 225.3 million people living in the U.S., equal to 67.9% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 109.9 million have had a booster, equal to 48.8% of the vaccinated population, and 23.9 million of those who are eligible for a second booster have had one, equal to 36.6% of those who received a first booster.

    Some 7.6 million people have had a shot of one of the new bivalent boosters that target the new omicron subvariants that have become dominant around the world.

    [ad_2]

    Source link

  • A strong fall COVID booster campaign could save 90,000 U.S. lives and avoid more than 936,000 hospitalizations, study finds

    A strong fall COVID booster campaign could save 90,000 U.S. lives and avoid more than 936,000 hospitalizations, study finds

    [ad_1]

    A strong fall COVID booster campaign could save about 90,000 people living in the U.S. from dying of the virus and avoid more than 936,000 hospitalizations, according to a new study by the Commonwealth Fund.

    As immunity wanes and new variants that can evade protection from early vaccines emerge, surges in hospitalizations and deaths are increasingly likely this fall and winter, the authors wrote. That makes it important that people get the bivalent boosters recently authorized by the Food and Drug Administration and help stop transmission, they wrote.

    Researchers analyzed three scenarios to evaluate the impact of vaccination on reducing fatalities, hospitalizations and medical costs to both the Medicare and Medicaid programs.

    The first measured the outcome if daily vaccination rates remain unchanged from current levels; they have gradually declined since the first wave of the omicron variant. Federal financial support has also not been replenished, amid a perception among many Americans that the pandemic is over and as congressional Republicans oppose legislative efforts to continue the pandemic fight.

    As of Oct. 3, some 68% of the U.S. population has had primary shots, but fewer than half of those have received a booster dose, and only 36% of those aged 50 and older have had a second booster.

    The second and third Commonwealth Fund scenarios looked at outcomes if rates increased by the end of 2022.

    In one scenario, researchers imagined booster uptake would track flu-shot coverage in 2020 to 2021. The other scenario assumed 80% of eligible individuals 5 and older get a booster by the end of 2022.


    Source: Commonwealth Fund

    The data found that more than 75,000 deaths could be prevented along with more than 745,000 hospitalizations if coverage reaches similar levels to 2021 to 2022 flu vaccination. The best scenario would save $56 billion in direct medical costs over the course of the next six months.

    “Stratifying by insurance type, we found direct medical costs would be reduced by $11 billion for Medicare alone under scenario 1 and $13 billion under scenario 2,” the authors wrote. “An additional $3.5 to $4.5 billion in savings would accrue to Medicaid. Even if the federal government paid all vaccination costs, accelerated campaigns would generate more than $10 billion in net savings from federal programs like Medicare and Medicaid.”

    The study comes as U.S. known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, with data not being collected.

    The daily average for new cases stood at 44,484 on Tuesday, according to a New York Times tracker, down 22% from two weeks ago. Cases are rising in most northeastern states by 10% of more, while cases in the are rising in the western states Montana, Washington and Oregon.

    The daily average for hospitalizations was down 12% at 27,334, while the daily average for deaths is down 8% to 393. 

    The new bivalent vaccine might be the first step in developing annual Covid shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to Covid could be challenging. Illustration: Ryan Trefes

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Long COVID, a condition that can encompass symptoms such as respiratory distress, cough, “brain fog,” fatigue and malaise that last 12 weeks or longer after initial infection, is becoming a long-term challenge as both employers and workers navigate an ever-mutating virus, according to Liz Seegert, writing for NextAvenue.org. The Centers for Disease Control and Prevention found that one in five COVID survivors younger than 65 experienced at least one incident that might be related to previous COVID-19 infection. Among those 65 and older, the rate was one in four. Their data also show that nearly three times as many people age 50 to 59 currently have long COVID than those 80 or older.

    • A retired judge opened a public inquiry on Tuesday into how Britain handled the coronavirus pandemic, saying bereaved families and those who suffered would be at the heart of the proceedings, the Associated Press reported. Former Court of Appeal judge Heather Hallett said the inquiry would investigate the U.K.’s preparedness for a pandemic, how the government responded, and whether the “level of loss was inevitable or whether things could have been done better.”

    With each mutation, the Covid-19 virus is becoming more transmissible. WSJ’s Daniela Hernandez breaks down the science of how Covid variants are getting better at infecting and spreading. Illustration: Rami Abukalam

    • Health experts are keeping an eye on new versions of the BA.5 omicron subvariant amid concerns those virus versions can evade the drugs developed to fight COVID, Salon reported. Of particular concern are two named BQ.1 and BQ.1.1, along with BA.2.75.2, which is spreading in Singapore, India and parts of Europe. Then there’s XBB, which some research suggest is the most antibody-evasive strain tested so far. The World Health Organization said in its weekly update on the virus that BA.5 descendent lineages continued to be dominant in the latest week, accounting for 80.8% of sequences shared through a global database. It also noted “increased diversity” within omicron and its lineages.

    • Eiger BioPharmaecuticals Inc.
    EIGR,
    -5.01%

    said Wednesday it will not pursue emergency authorization of its experimental treatment for mild and moderate COVID-19 infections. It had asked the Food and Drug Administration to consider an EUA application based on data from the Together trial, a Phase 3 study that has assessed 11 possible treatments for COVID-19 that is being conducted in Brazil and Canada. Eiger said the FDA instead recommended the company consider running its own pivotal trial for peginterferon lambda that would support full approval of the drug.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 619.2 million on Wednesday, while the death toll rose above 6.55 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 96.5 million cases and 1,060,446 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 225.3 million people living in the U.S., equal to 67.9% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 109.9 million have had a booster, equal to 48.8% of the vaccinated population, and 23.9 million of those who are eligible for a second booster have had one, equal to 36.6% of those who received a first booster.

    Some 7.6 million people have had a shot of the new bivalent booster that targets the new omicron subvariants that have become dominant around the world.

    [ad_2]

    Source link

  • Midterm elections: Republicans regain edge over Democrats in generic ballot, scoring biggest advantage in 2 months in key indicator

    Midterm elections: Republicans regain edge over Democrats in generic ballot, scoring biggest advantage in 2 months in key indicator

    [ad_1]

    The Republican Party has an edge again in the generic ballot, and that advantage has reached a level last seen in late July, according to a RealClearPolitics average for that closely watched indicator.

    That could be another sign that the GOP may be getting back some momentum as November’s midterm elections approach, after Democratic prospects improved during the summer.

    Republicans are now scoring 46.0% support in the RCP average of generic ballots, a percentage point ahead of Democrats at 45.0%.

    The GOP hit a 1-point edge last Wednesday, then saw a dip, but as of Tuesday was back at that level, as shown in the chart below.

    It’s not a big advantage, but it’s the best showing for Republicans in RCP’s data for generic ballots since July 28, as Democrats had the advantage for much of August and September.

    Related: If this seat flips red, Republicans will have ‘probably won a relatively comfortable House majority’

    Also read: ‘Republican control of the House is not a foregone conclusion,’ says political analyst


    RealClearPolitics

    The generic ballot refers to a poll question that asks voters which party they would support in a congressional election without naming individual candidates. Analysts tend to see it as a useful indicator.

    Other websites focused on political analysis and forecasting, such as FiveThirtyEight, still show Democrats with an edge in their data for generic ballots.

    Election Day for the midterm contests is now five weeks away. Democrats have focused their campaigns on abortion rights after the Supreme Court’s June decision that overturned Roe v. Wade, while Republicans have seized on Americans’ frustration with high inflation.

    The additional chart below is interactive and shows RCP’s data for the generic ballot over a longer time frame.

    Related: Biden to talk up Democrats’ support for abortion rights, with midterm elections now just 5 weeks away

    And see: New poll finds just 30% of Americans approve of how Biden is handling inflation

    Plus: Republicans’ chances for taking control of Senate rebound to 46%, a level last seen about 8 weeks ago

    [ad_2]

    Source link

  • CDC scraps travel health notices as countries slow testing, and study confirms Republican-leaning counties suffered more COVID deaths than Democrat-leaning ones

    CDC scraps travel health notices as countries slow testing, and study confirms Republican-leaning counties suffered more COVID deaths than Democrat-leaning ones

    [ad_1]

    The U.S. Centers for Disease Control and Prevention has dropped its country-by-country COVID-19 travel health notices that it began issuing early in the pandemic, the Associated Press reported. 

    The reason: Fewer countries are testing for the virus or reporting the number of COVID cases. That limits the CDC’s ability to calculate travelers’ risk, according to the agency.

    CDC spokeswoman Kristen Nordlund said the agency will only post a travel health notice for an individual country if a situation such as a troubling new variant of the virus changes CDC travel recommendations for that country.

    The CDC still recommends that travelers remain up-to-date on vaccines and follow recommendations found on its international travel page.

    From the CDC: Stay Up to Date with COVID-19 Vaccines Including Boosters

    A new study from the National Bureau of Economic Research has confirmed that political affiliations played a key role as a risk factor for dying of COVID, finding evidence that Republican-leaning counties suffered higher death rates than Democratic-leaning ones.

    “We estimate substantially higher excess death rates for registered
    Republicans when compared to registered Democrats, with almost all of the difference concentrated in the period after vaccines were widely available in our study states,” the authors, Jacob Wallace and Jason L. Schwartz of the Yale School of Public Health, and Paul Goldsmith-Pinkham of the Yale School of Management wrote.

    “Overall, the excess death rate for Republicans was 5.4 percentage points (pp), or 76%, higher than the excess death rate for Democrats.”

    The researchers used data from Ohio and Florida and matched 2017 voter registration data with mortality data from 2018 to 2021. They also found a link between political affiliation and views on vaccines, with Republican-leaning counties showing far lower vaccination rates.


    Source: NBER paper

    In the U.S., known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, where the data are not being collected.

    The daily average for new cases stood at 45,495 on Monday, according to a New York Times tracker, down 24% from two weeks ago. Cases are rising in 11 states plus Washington, D.C. They are up by double-digit percentages in Rhode Island, Massachusetts and Vermont.

    The daily average for hospitalizations was down 11% at 27,854, while the daily average for deaths is down 12% to 386. 

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Norwegian Cruise Line Holdings Ltd.
    NCLH,
    +16.84%

    is removing all COVID testing, vaccination and masking requirements from its health and safety protocols. The company said the new protocols, which follows “significant, positive progress” in the public health environment, will be effective Oct. 4. “Health and safety are always our first priority; in fact, we were the health and safety leaders from the very start of the pandemic,” said Chief Executive Harry Sommer. “Many travelers have been patiently waiting to take their long-awaited vacation at sea and we cannot wait to celebrate their return.” 

    See also: Would you take a cruise without such COVID-19 testing, vaccination and masks? MarketWatch asked health experts to weigh in.

    • Ringo Starr has test positive for COVID, forcing the former Beatle to cancel scheduled concerts in Canada with his All Starr Band, the AP reported. Five concert dates from Tuesday to Sunday — in Winnipeg, Manitoba; Saskatoon, Saskatchewan; Lethbridge, Alberta; and the British Columbia cities of Abbotsford and Penticton — will be rescheduled. “Ringo hopes to resume as soon as possible and is recovering at home. As always, he and the All Starrs send peace and love to their fans and hope to see them back out on the road soon,” said a statement from the band.

    The new bivalent vaccine might be the first step in developing annual Covid shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to Covid could be challenging. Illustration: Ryan Trefes

    • A federal appeals court in New Orleans on Monday became the latest to hear arguments on whether President Joe Biden overstepped his authority with an order that federal contractors require that their employees be vaccinated against COVID, the AP reported separately. The contractor mandate has a complicated legal history. It is being challenged in more than a dozen federal court districts, and the mandate has been blocked or partially blocked in 25 states. 

    • The Chinese resort city of Sanya has ordered all tourists to take PCR tests, and those who fail to do so by noon on Tuesday will be slapped with a yellow code restricting their mobility, according to local officials, the South China Morning Post reported. The city in the southern province of Hainan logged two asymptomatic Covid-19 cases on Monday. It carried out a round of mass testing and locked down several areas in Haitang district, including a scenic island that received around 2,000 tourists on Monday.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 618.7 million on Tuesday, while the death toll rose above 6.54 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 96.4 million cases and 1,059,888 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 225.3 million people living in the U.S., equal to 67.9% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 109.9 million have had a booster, equal to 48.8% of the vaccinated population, and 23.9 million of those who are eligible for a second booster have had one, equal to 36.6% of those who received a first booster.

    Some 7.6 million people have had a shot of the new bivalent booster that targets the new omicron subvariants that have become dominant around the world.

     

    [ad_2]

    Source link